Wikipedia talk:WikiProject Medicine/Archive 114

Nobody reads the citations
m:Research:Characterizing Wikipedia Citation Usage seems to be about figuring out how often readers (logged-out users) actually look at or open links in the citations. Maybe we'll finally learn how much or how little interest readers have in sources. WhatamIdoing (talk) 19:30, 21 June 2018 (UTC)
 * Great to see this being done. Interested in seeing the results. Folks at pubmed say that people very rarely click reference links so I imagine that will be the result. Doc James  (talk · contribs · email) 19:34, 21 June 2018 (UTC)


 * Why would most people read those in the first place? If I want to know who the President of the Democratic Republic of the Congo is, I see it's Joseph Kabila. If I want to know when he came in power, I see it's 17 January 2001. What use do I have, as a reader, for the 15 references of President of the Democratic Republic of the Congo or the 39 references of Joseph Kabila? Headbomb {t · c · p · b} 19:46, 21 June 2018 (UTC)
 * I have been restrainedly rude at m:Research:Characterizing Wikipedia Citation Usage. IMO, readers will rarely click through on either bluelinks or citations. What readers need is the assurance that a responsible editor has checked and validated those links. Mechanical counting is worse than useless. Narky Blert (talk) 22:10, 21 June 2018 (UTC)

I was under the impression that this research had been performed and was published a few years ago. I can't remember the exact numbers, but the rate was somewhere around 1/1000-2000 article views per source view. That also chimes rather well with the statistics of referrals from Wikipedia to SBU. I know mentioned similar numbers from the NIH pages, which was a while ago, possibly before the 2013(14?) referral breaking. (My SBU stats are similarly not broken, because sv-wiki never broke their referrers.) We have the problems that: 1) a single source can carry more than one link; 2) the referral mechanism has been broken on en-wiki; and 3) we do not standardize our links. Clickthroughs also of course, depend on article type, and without any stratification according to number of sources in an article, or especially topic of the article — this research will not be more useful than what estimates we already have. I'm very inclined to believe that medical articles differ from other articles when it comes to source clickthrough. I haven't read their proposal, but I hope they're aware of these things. Carl Fredrik  talk 04:57, 22 June 2018 (UTC)
 * I thought that the metric was 10,000 pageviews means 1 clickthrough to a typical single citation in the references list. I do not recall anyone ever publishing information like this.
 * WhatamIdoing characterized this research as including how often people look at citations. I do not see that as a goal in the research - they are only considering click throughs and not on-wiki citation-reading.  Blue Rasberry   (talk)  15:23, 26 June 2018 (UTC)
 * I believe that "How frequently are references clicked (e.g., what fraction of pageviews entails a reference click)?" is about how many times people click on the little blue clicky numbers inside the articles, and not how often they click through the citation on any URL that might be present in that citation. WhatamIdoing (talk) 20:25, 26 June 2018 (UTC)

Standing desk
Should Standing desk be added to Wikiproject Medicine?

Thanks,

JenOttawa (talk) 17:45, 25 June 2018 (UTC)
 * 'Fraid so (money quote: "A 1995 study of pregnant women found that prolonged standing at work affects birthweight"). Alexbrn (talk) 17:47, 25 June 2018 (UTC)
 * Yes, the article is making claims that it is a subject with health benefits. Natureium (talk) 17:50, 25 June 2018 (UTC)
 * As it is not primarily a medical topic I would say no should not be added. Health claims even if in an article not tagged as WPMED still required MEDRS sourcing. Doc James  (talk · contribs · email) 17:53, 25 June 2018 (UTC)
 * Where's the line between a medical topic and just medical related? Isn't the purpose of the standing desk trend because of the popular media claiming that sitting is killing people? Natureium (talk) 18:00, 25 June 2018 (UTC)
 * We have some guidance WikiProject_Medicine/Assessment Doc James  (talk · contribs · email) 18:03, 25 June 2018 (UTC)
 * Thanks. Natureium (talk) 18:04, 25 June 2018 (UTC)
 * Thanks for the quick response and feedback. I am adding this Cochrane Review in: http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD010912.pub4/abstract
 * So far I have "Low-quality evidence indicates that providing employees with a standing desk option may reduce the length of time some people sit in the first year, however, this reduction may wane with time. It is not clear how standing desks compare with other work-place suggestions and interventions to reduce the length of time employees are sitting during the workday."
 * Definitely no evidence so far that I can see of health-benefit. I am looking for something from the Cochrane full text report to add in regarding evidence for reducing sitting while at work (or lack thereof). Googling it definitely seems like these are marketed to have health benefits.
 * JenOttawa (talk) 18:07, 25 June 2018 (UTC)
 * This is a tangent, and should not be taken as disagreeing with any of the foregoing comments:
 * I've been thinking about how we (society; the lay media) often seem to define "healthy". It usually seems to mean "contributes to weight loss" or "promotes cardiovascular fitness" in some circumstances.  The marketers seem to have been promoting standing desks as contributing to the first, but it's not going to promote other kinds of fitness, such as flexibility.  (And just imagine the effect on the knees, if you're standing up for hours in high heels.)
 * I've mostly been thinking about "healthy food". I talked to a caterer the other day.  She said that she gets clients with all sorts of dietary requirements.  She spends a lot of time looking for recipes that fit multiple categories (e.g., a roasted vegetable platter that is simultaneously gluten-free, paleo, and vegan), but nobody ever seems to ask for an actual health-promoting diet (like the DASH diet).
 * Maybe we should avoid the word "healthy" in writing, and try to be more specific when/if we can. WhatamIdoing (talk) 21:06, 26 June 2018 (UTC)

AfD input: List of questionable diseases
Input welcome at Articles for deletion/List of questionable diseases. Bondegezou (talk) 18:25, 26 June 2018 (UTC)

give opinion(gave mine)--Ozzie10aaaa (talk) 10:34, 27 June 2018 (UTC)

Retraction of a cited NEJM article
A 2013 article in the New England Journal of Medicine, "Primary prevention of cardiovascular disease with a Mediterranean diet", has now been retracted. See Talk:Predimed. It is also cited in 2013 in science. I noted the retraction in both places but someone more conversant with the subject and the conventions of this project should look at them. Kablammo (talk) 16:21, 14 June 2018 (UTC) I have now deleted the item from 2013 in science. Kablammo (talk) 17:17, 14 June 2018 (UTC)
 * It is not cited in our article on Mediterranean diet, but is cited in some of the sources relied on by that article. Kablammo (talk) 16:31, 14 June 2018 (UTC)
 * ...and that could be problematic in terms of references...IMO--Ozzie10aaaa (talk) 10:43, 27 June 2018 (UTC)

Please read ncbi conclusion about Mediterranean diet and its relation with Heart problems

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339461/

(Subrahmanya preethamm (talk) 16:48, 14 June 2018 (UTC))


 * The relation is not in question; the adequacy of the source (which is cited in the article you mention) is the issue. Kablammo (talk) 17:13, 14 June 2018 (UTC)
 * The "NCBI" didn't conclude anything. It merely provided a copy of this paper, which is, just like it provides copies and links to thousands of other papers.
 * The science news reporting that I've seen indicates that the original is being retracted, and a revised version is being published. The main difference is (reportedly) that the original said that following the diet definitely caused the reduced mortality and morbidity, and the revised version is going to say that there was reduced mortality and morbidity, without declaring the diet to be the sole or primary cause of that healthy outcome.  WhatamIdoing (talk) 17:44, 14 June 2018 (UTC)
 * Revised version. Kablammo (talk) 17:50, 14 June 2018 (UTC)
 * This article is about a primary study which has been retracted. Is it even worthy of an article? Would someone like to propose it for deletion? Kablammo (talk) 01:58, 15 June 2018 (UTC)

Another better review for better conclusion

https://www.ijser.org/researchpaper/Review-of-Literature-The-Effects-of-Mediterranean-Diet-on-Cardiovascular-Disease.pdf

https://www.ncbi.nlm.nih.gov/pubmed/29177567

(Subrahmanya preethamm (talk) 08:46, 15 June 2018 (UTC))
 * Yes we are all aware of the news. We do not react to news in WP - we are a lagging indicator. We will see how reviews deal with this and deal with it then. Jytdog (talk) 20:16, 15 June 2018 (UTC)
 * As the article now stands, it relies on a primary study which has been retracted. Are we to await a secondary review when the study itself is erroneous, as acknowledged by its authors? Kablammo (talk) 21:19, 15 June 2018 (UTC)

Please read following for some more information

http://www.tmg.org.rs/v380405e.pdf

https://pdfs.semanticscholar.org/7e40/64be6f6c45e50799a8f20c86564c005a7cc4.pdf

http://www.revespcardiol.org/en/mediterranean-diet-and-cardiovascular-prevention/articulo/S1885585713001801/

The American Heart Association/American College of Cardiology[32], the European Society of Cardiology[33] and the National Heart Foundation of Australia (www.heartfoundation.org.au) are three societies that all recommend the Mediterranean diet to reduce cardiovascular risk

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980102/
 * we can edit Mediterranean diet by confirming Mediterranean diet prevents cvc and some more diseases

(Subrahmanya preethamm (talk) 15:15, 16 June 2018 (UTC))

Predimed
Having received no clear answer here, I have submitted this article, based on a primary study that has now been retracted, for proposed deletion. It was created by one editor who has edited nothing else. It is not clear to me that, retracted or not, Wikipedia should have an article on a primary medical study which is not covered by secondary reviews. If some other action should be taken, perhaps someone here will do so. Or if the article should better go to AFD, perhaps someone more conversant with the subject will do so. Kablammo (talk) 21:35, 16 June 2018 (UTC)
 * Hello. I have unPRODed the article. As I wrote in the article talk page (before I noticed this discussion), there are reliable secondary sources about this study, including at least two very detailed New York Times article, so it very easily passes WP:GNG. Thanks and regards, Biwom (talk) 03:25, 17 June 2018 (UTC)
 * Articles about clinical trials should usually be treated more like historical events than like scientific research. The question for the article to answer is "Who did what, when, and where?" rather than "Did the result get statistically significant results while following accepted scientific standards?"  In some cases, the fact of a paper being retracted is what makes the event notable.  WhatamIdoing (talk) 04:49, 17 June 2018 (UTC)
 * The article as it now stands likely is misleading. But as it is well outside my comfort zone I am withdrawing from further participation. Kablammo (talk) 12:37, 17 June 2018 (UTC)
 * In some cases, the fact of a paper being retracted is what makes the event notable. Case in point: Retracted article on dopaminergic neurotoxicity of MDMA (that publication wasn’t a clinical trial, but this is a Wikipedia article about a notable retracted study).  Seppi  333  (Insert 2¢) 16:24, 17 June 2018 (UTC)
 * Geez oh man. It is a book report not a WP article. Jytdog (talk) 15:11, 18 June 2018 (UTC)

Identifiers deprecated
Are the identifiers MeSH ID and ICD-9 now deprecated? I just spotted a bot removing them from Wikidata (example: https://www.wikidata.org/w/index.php?title=Special%3AEntityPage%2FQ133087&curid=134863&diff=702702152&oldid=702662946). Are we modifying our templates to reflect these changes? --RexxS (talk) 03:14, 26 June 2018 (UTC)
 * MeSH is part of the NIH not ICD so not deprecated. We are still using ICD9 in Canada for billing so definitely not deprecated. Doc James  (talk · contribs · email) 17:52, 26 June 2018 (UTC)
 * It looks like there was a minor hiccup in the bot (or a data source used by the bot?), and that it's being fixed. WhatamIdoing (talk) 21:08, 26 June 2018 (UTC)
 * It's restored the MeSH but not ICD-9. I've left a note at d:User talk:ProteinBoxBot, but it may be that the bot operator needs to understand the problems caused by unilaterally deciding that that an identifier is deprecated. --RexxS (talk) 22:30, 26 June 2018 (UTC)
 * One more reason why we host stuff locally I guess... Doc James  (talk · contribs · email) 11:27, 28 June 2018 (UTC)

Cochrane-Wikipedia Editathon
Hi WikiProject Med, I am organizing an hour-long "edit-a-thon" on Thursday (3-4pm BST, 10-11 EST). The Cochrane interns will continue to find appropriate Cochrane evidence that will help improve the evidence base of med articles. This evidence will be paraphrased into their own words and will be inserted it into articles as appropriate per MEDRS. I will be online moderating and editing myself during this time. I just wanted to let you know in advance that this activity will be happening. If you happen to notice editing activity by the Cochrane group, it would be great if we could give the new editors a warm welcome. :) It would be nice to encourage some of these individuals to stick around and contribute to WP:MED on a regular basis. I will be buzzing around to try and clean up any citation errors, lay term errors, etc., when the event is over. If you have any questions or comments, please do not hesitate to let me know! I have set up a dashboard here. Thank you for your support! JenOttawa (talk) 14:48, 26 June 2018 (UTC)
 * thank you for info--Ozzie10aaaa (talk) 17:14, 26 June 2018 (UTC)
 * Very cool that you are organizing this "edit-a-thon". I created an Event Time Announcer for you to use if you wish. As someone who confuses time zone differences frequently, I find these little tools to be helpful. ;o)  - Mark D Worthen PsyD   (talk)  02:50, 27 June 2018 (UTC)
 * , Thank you for creating this link. It is very helpful! Not sure why I chose to use quotations on edit-a-thon...at least I was correct with the dashes (according to the wiki page). I appreciate your support. JenOttawa (talk) 03:27, 27 June 2018 (UTC)
 * , may I assume that I have found a kindred spirit? I mean, not everyone ponders the appropriate use of quotation marks--only the fabulous word geeks of the world! :0) ¶ Edit-a-thon is not a neologism, which is one of Garner's five reasons to use quotation marks. On the other hand, it is a new word for most people. I had not encountered "edit-a-thon" before, and I found the quotation marks to be helpful.  - Mark D Worthen PsyD   (talk)  05:45, 27 June 2018 (UTC)
 * About that word: Outside the core Wikipedia community, it is unfamiliar jargon, and it's (believed to be) derived from hackathon, which carries connotations of nearly endless, strenuous activities (i.e., marathons) and brogrammer culture.  (The alternative, at least within the US, is that potential participants will believe that it's a fundraiser similar to a Walkathon or Telethon.)  There's been some discussion among event organizers about using "edit party" or "Wikipedia editing party" as an alternative.  More people will be able to figure out what a Wikipedia editing party is, it sounds like it's more fun, and it might increase participation.  WhatamIdoing (talk) 15:39, 27 June 2018 (UTC)
 * Thanks for the interesting history of the term "edit-a-thon". I think that word is a little strange, but it seems a little more interesting than attending an "editing party". Natureium (talk) 16:09, 27 June 2018 (UTC)
 * Wow thanks for all the interesting information and Friday night reading :-). I envisioned editathon in the marathon sense. It looks like we will have about 5 participants, so I do not expect a huge amount of scrambling around to deal with content. I will do my best to review all of the submissions as soon as it is over. I am doing this remotely (video-chat from Ottawa to the UK) so, unfortunately, I will not be able to entice people with coffee.JenOttawa (talk) 02:19, 28 June 2018 (UTC)
 * The "edit-a-thon" just ended. The team accidentally worked an extra 25 minutes as everyone seemed engaged and did not notice the time! I would greatly appreciate any constructive feedback or suggestions that any of you have as to the success of this event and whether or not this method to recruit new editors, engage people on WP:MED, and improve the evidence base of MED articles is effective. The actual pages edited are not yet updated on the dashboard, I would guess about 25 articles were edited with Cochrane evidence. Thank you to everyone for your patience with the new editors. I encouraged them to "be bold", and I tried to clean up all the edits. Being only human, I could have missed some.JenOttawa (talk) 15:43, 28 June 2018 (UTC)

Publication on "Effects of Contributor Experience on the Quality of Health-Related Wikipedia Articles"
A new publication just caught my eye: https://www.jmir.org/2018/5/e171/ JenOttawa (talk) 00:33, 29 June 2018 (UTC)
 * It's interesting that they chose Health and Fitness instead of Medicine. And I'm very surprised than only .5% of articles had ever had a maintenance tag. Natureium (talk) 00:59, 29 June 2018 (UTC)
 * Good point. "The articles that were sampled for this study only constitute a part of the medical content that is available at Wikipedia". I am assuming that some of the health and fitness articles part of WP:MED. I have never looked at this group.JenOttawa (talk) 01:18, 29 June 2018 (UTC)
 * WikiProject Health and Fitness appears to be "inactive". WikiProject_Health_and_fitness JenOttawa (talk) 01:20, 29 June 2018 (UTC)

Bot requests
If you have comments for this bot request I've made, please follow the link. Headbomb {t · c · p · b} 04:39, 29 June 2018 (UTC)

Lists of passing mentions of a disease
Discussion here Doc James  (talk · contribs · email) 18:56, 28 June 2018 (UTC)
 * commented--Ozzie10aaaa (talk) 10:19, 29 June 2018 (UTC)

Cretinism merge with Congenital hypothyroidism
Hello, referring to an old discussion here it seems like the merge might make sense if we're following the MoS. i.e do medical professionals still use the term "cretinism" at all? And if not, it seems like merging it with Congenital hypothyroidism would be the sensible thing to do. Battleofalma (talk) 10:53, 27 June 2018 (UTC)
 * ICD-10 lists cretinism (aka congenital iodine-deficiency syndrome) and congenital hypothyroidism as separate conditions:, and or . ICD-11 maintains this separation at 5B5K.3 and 5A00.0 respectively. That said; a search on pubmed for cretinism pulls several recent articles with titles containing congenital hypothyroidism. Unfortunately I don't have access to the full texts to get context of how cretinism is used within them. Little pob (talk) 12:58, 27 June 2018 (UTC)
 * Yes, there seems to be a bit of ambiguity. If we maintain that there is a separation though and these still warrant separate articles, then perhaps the solution is to rename Cretinism as "Congenital iodine-deficiency syndrome". In the same way Down syndrome is not titled "Mongolian imbecility". Battleofalma (talk) 09:52, 28 June 2018 (UTC)
 * Cretinism is an old term for the state that occurs when congenital hypothyroidism remains untreated. Have gone ahead and moved it to the modern term (the one in the ICD10). Doc James  (talk · contribs · email) 11:22, 28 June 2018 (UTC)
 * Good, thanks. Just trying to think of other articles where we might still be using antiquated terms we have better terms for now. Battleofalma (talk) 10:04, 29 June 2018 (UTC)
 * additional ref (for moved page)--Ozzie10aaaa (talk) 10:32, 30 June 2018 (UTC)

Notable genes?
Can we get some opinions on what constitutes notability for inclusion in the list of "notable genes" on List of human genes? I posted on the talk page a while ago, but got no response. What makes a gene notable is highly debatable. Certainly BRCA1/2 and P53 should be notable genes, but some on that list seem like they might just be someone's pet project. Natureium (talk) 14:00, 29 June 2018 (UTC)
 * We should just convert this to Lists of human genes (WP:LISTOFLISTS) and link to the chromosome lists and articles like List of genes mutated in cutaneous conditions. The "notable" gene list is always going to be indiscriminate. – Finnusertop (talk ⋅ contribs) 14:14, 29 June 2018 (UTC)
 * Yeah, I'm thinking it might be best to remove the list. Natureium (talk) 14:18, 29 June 2018 (UTC)
 * Human gene articles are pretty much never nominated for deletion and the only AfD on a human gene that I recall concluded that they are automatically notable. So I agree that "notable" does not mean much in this context. Jo-Jo Eumerus (talk, contributions) 14:21, 29 June 2018 (UTC)
 * Clearly there would have to be different criteria for inclusion in this list and notability sufficient for an article. We already have List of genetic disorders, which serves as somewhat of a list of notable genes. Natureium (talk) 14:40, 29 June 2018 (UTC)
 * They would all be notable would they not? Doc James  (talk · contribs · email) 16:41, 29 June 2018 (UTC)
 * What I mean is, unless we want to have an indiscriminate list of ever-expanding length on List of human genes, we should either decide what makes a gene important enough to be listed on that page, or remove the list and just have links to subpages. Natureium (talk) 16:44, 29 June 2018 (UTC)
 * The list is large but finite. If subdivided by chromosome, manageable. The criteria for notability is relatively straight forward to define:  known function or disease linkage supported by a reliable source.  There are a border line cases of course: genes with a probable function based on analogy to a closely related gene of known function. Boghog (talk) 19:37, 29 June 2018 (UTC)
 * I'm not talking about all the separate lists of genes. This page has lists of lists, and then also a list of "notable genes". At this point, I'm going to just delete this list and if anyone has some finite criteria, they can undo it. Natureium (talk) 19:42, 29 June 2018 (UTC)
 * I think that Finnusertop has the right idea: there are lots of ways to make lists (Boghog's idea of dividing by location could be accomplished with a List of genes on chromosome 1, etc.), and a central page to find all the lists might be more useful than a page that contains some, but not all, of the WP:Notable (or even noteworthy) genes.  WhatamIdoing (talk) 06:41, 30 June 2018 (UTC)
 * While not named as "list of", this is essentially what all of the links on that page are. e.g. Chromosome 1 (human) lists the genes on chromosome 1 that there is an article for. Natureium (talk) 15:01, 30 June 2018 (UTC)

Postmenopausal hormone therapy article title
What to call this article? See Talk:Postmenopausal hormone therapy. A permalink for the section is [https://en.wikipedia.org/w/index.php?title=Talk:Postmenopausal_hormone_therapy&oldid=848330812#Strange_title_-_is_this_%22postmenopausal_hormone_therapy%22? here]. Flyer22 Reborn (talk) 08:04, 1 July 2018 (UTC)


 * give opinion(gave mine)--Ozzie10aaaa (talk) 14:46, 3 July 2018 (UTC)

Conflicts of interest in academic publishing
The contents of the conflicts of interest in academic publishing article may be of interest to editors here. The article is currently in DYK on the main page, and extensively discusses medical articles (the medical community writes about this subject more than other academic fields). While it's extensively referenced, it is not well-written (I wrote most of it, so I should know), with a rather atomized structure and many statements which are more a summary of the references than a phrase in an article. Edits and criticism would be very welcome, if anyone feels so inclined.

Thanks to for prompting me to write this article (and to both Headbomb and others for contributing to it). HLHJ (talk) 16:26, 3 July 2018 (UTC)


 * I did? I don't remember doing so, but if the end product is better coverage of encyclopedic topics, I'm all for it. Headbomb {t · c · p · b} 16:30, 3 July 2018 (UTC)

Links to DAB pages
Despite this WikiProject's valiant efforts to keep on top of these problems, new medicine-related links to DAB pages which need expert attention keep getting created all the time. This is my latest batch. As always, if you do solve a problem, take off the dn tag, and post done here. Thanks in advance, Narky Blert (talk) 21:21, 3 July 2018 (UTC)
 * Vaginal cuff
 * Wilderich von Walderdorff
 * List of MeSH codes (H01) (2 links)
 * Reannealing ✅
 * Selector-technique ✅
 * Parathyroid hormone ✅ (was vandalism)
 * Neotenic complex syndrome ✅
 * Memory B cell ✅
 * Sensor ✅
 * Gerald Edelman ✅
 * Boston Scientific ✅
 * NOTCH2NL ✅

Medical outsourcing
Just created that. it is a bit crappy. Also created Category:Medical outsourcing... Jytdog (talk) 06:05, 6 July 2018 (UTC)
 * Added Travel nursing. There's probably a few other candidates scattered around. Basie (talk) 08:13, 6 July 2018 (UTC)

Request for more information in article
At Talk:Breathing_gas. I don't know whether any of you think this article should be expanded to include the requested information. Cheers, &middot; &middot; &middot; Peter (Southwood) (talk): 16:04, 6 July 2018 (UTC)
 * commented--Ozzie10aaaa (talk) 21:02, 6 July 2018 (UTC)

Frequently misinterpreted sourcing policy
Some here may want to weigh in on this at Wikipedia talk:Frequently misinterpreted sourcing policy. Flyer22 Reborn (talk) 06:02, 1 July 2018 (UTC)
 * commented--Ozzie10aaaa (talk) 11:42, 2 July 2018 (UTC)
 * Fairly daft essay acting as a coatrack for some very daft axe-grinding. We've had this kind of thing before and procedurally it's probably just best to let it sink into well-deserved obscurity: it is just after just all an editor's opinion. Alexbrn (talk) 16:55, 2 July 2018 (UTC)
 * The difference as I see it is that advocacy ducks is less wrong and more just incoherent, while this essay includes a whole bunch of falsehoods and mistakes regarding the distinction between objectivity and neutrality as well as that between original/primary research and secondary sources/reviews. It does however include one very constructive discussion, though it phrases it in a less than useful manner, simply assuming that what is written in that essay will become the de facto methodology for Wikipedia. The wish to include primary sources together with secondary sources is a good one, and acknowledges a problem in academia where citations point to sources in support of statements which in turn cite something else, which in turn cites something that doesn't even support the statement it is later used to support. I've meant to write an essay on WP:Citing citations. However, there are three problems with the idea of simply tacking primary sources to secondary sources:
 * Technical — we need to differentiate between primary and secondary sources clearly in the reference list, and these is no template to tie primary sources to secondary sources.
 * Risks promoting biased results — Even if we require secondary sources next to all primary sources, the inclusion of primary sources will increase their presence on WP, and thus make them seem more important. The selection of which primary source is included is just as likely to be as biased as any primary source included on its own.
 * Time — any introduction of primary sources next to secondary sources will require more work from editors to ensure that bias is not included in the selection of which primary sources are chosen for inclusion — and time is required to vet not only the secondary source, but also that the primary source is the best one of all the primary sources cited.
 * So to cut a long story short, I disagree with everything EDIT: much in the essay, as anyone who is interested enough to want a primary source can read the secondary sources we cite and find the original research from there. Carl Fredrik  talk 20:18, 2 July 2018 (UTC)
 * I wonder if has anything to say about this.  Carl Fredrik  talk 20:22, 2 July 2018 (UTC)

The title "Frequently misinterpreted sourcing policy" is not what the page is about. It claims "This is a list of key points of frequently misinterpreted sourcing policy, guidelines, and community norms at Wikipedia." It is not about that. It is a disagreement with sourcing policy. It is not about misinterpreting policy. If it was about misinterpreting policy then it would be providing specific information on what is being misinterpreting rather than dispute the reliability of sources such as the US FDA. It is about "Frequent disagreements with sourcing policy" or "Frequent disputes with sourcing policy". The title should be changed to reflect what the page is about. QuackGuru ( talk ) 15:11, 7 July 2018 (UTC)
 * This appears to have originated in a very different context at Village pump (policy). WhatamIdoing (talk) 18:25, 7 July 2018 (UTC)

ICD-11
Has been released. https://icd.who.int/ frameless|right Doc James (talk · contribs · email) 15:38, 20 June 2018 (UTC)
 * Is it time to migrate ICD-11 to a separate article? Looie496 (talk) 13:03, 21 June 2018 (UTC)
 * I'm in favour of a early WP:SPINOFF for this. Although the ICD article is "only" ~36kB; it'll be more work to WP:SPLIT later (ie once ICD-11's adoption begins).
 * At some point; it'll also need adding to . Little pob (talk) 15:37, 21 June 2018 (UTC)
 * Support both those suggestions. Doc James  (talk · contribs · email) 19:34, 21 June 2018 (UTC)
 * ↑Support. I'm not an expert on ICD, but from what I've read, ICD-11 introduces significant changes/developments in how to best conceptualize, organize, identify/label, and code diseases, injuries, etc. So another important reason to create a separate article now. ¶ I have read the psych section; submitted 5 proposals and commented on a couple. It is fantastic that WHO has--and will continue to--solicit input from anyone who has access to the Internet and can support their proposal(s) with scientific evidence. On the other hand, WHO has made a mistake that so many science organizations (and other groups) make. It goes something like this: "We are some of the most intelligent people in the world. Therefore, we don't need some snooty librarian types nitpicking how we write things up." Consequently, at least in the psych section, the median writing quality score is about a "C", which is not good for a classification system that seeks achieve precision, reliability, and validity.  - Mark D Worthen PsyD   (talk)  01:51, 29 June 2018 (UTC)
 * agree as well--Ozzie10aaaa (talk) 10:47, 8 July 2018 (UTC)

unassessed articles
any help w/ Medical unassessed articles which is around 500 would be appreciated, thanks--Ozzie10aaaa (talk) 14:44, 3 July 2018 (UTC)


 * It's been in the thousands before. The easiest way to reduce the sheer numbers is to find the BLPs in Category:Unassessed medicine articles and paste   on most of them (on the talk page, to replace whatever WikiProject Medicine template is currently there).  (Most of biographies are stubs.)  This is easy work that even inexperienced editors can be successful at.  (In fact, assessing articles is how I got involved in this group.)  WhatamIdoing (talk) 21:20, 3 July 2018 (UTC)


 * I got through about 100 of them. We have some interesting and some strange articles. Natureium (talk) 23:25, 3 July 2018 (UTC)
 * thanks Natureium--Ozzie10aaaa (talk) 00:06, 4 July 2018 (UTC)
 * A number of them are typically also paid for articles created by socks. Remember to mark those as appropriate. Doc James  (talk · contribs · email) 11:03, 8 July 2018 (UTC)

Request for input
This discussion about scope and naming on List of questionable diseases could probably use the input of folks who "know stuff" about medicine. G M G talk  11:24, 4 July 2018 (UTC)
 * article has had recent issuesArticles_for_deletion/List_of_questionable_diseases--Ozzie10aaaa (talk) 19:42, 5 July 2018 (UTC)
 * Help still needed. The AfD decided keep but tasked us with renaming the article. So far, it has proven difficult to get consensus on what the article is about and thus on what a new name should be. The article has been extensively edited since the AfD result, but not all those edits have been welcomed. And debate continues over the applicability of WP:MEDRS. Bondegezou (talk) 15:22, 8 July 2018 (UTC)

Help wanted
For a number of years we have been experiencing a steady decline in the number of administrators as a result of attrition and a declining number of editors willing to consider adminship. Things have reached a point where we are starting to experience chronic backlogs in important areas of the project including noticeboards, requests for closure, SPI, CSD & etc. If you are an experienced editor with around two years (or more) of tenure, 10k edits give or take and no record of seriously disruptive behavior, please consider if you might be willing to help out the community by becoming an administrator. The community can only function as well as we all are willing to participate. If you are interested start by reading WP:MOP and WP:RFAADVICE. Then go to WP:ORCP and open a discussion. Over the next few days experienced editors will take a look at your record and let you know what they think your chances are of passing RfA (the three most terrifying letters on Wikipedia) as well as provide you with feedback on areas that might be of concern and how to prepare yourself. Lastly you can find a list of experienced editors who may be willing to nominate you here. Thank you and happy editing... [Note:This page may not be on my watchlist so if you want to reply to me, please either ping me or drop me a line on my talk page.] -Ad Orientem (talk) 01:49, 4 July 2018 (UTC)
 * I'm not qualified to be an admin, but if I were I would think thrice about throwing my name into the hat. Some of the discussions about proposed admins that I've read have seemed brutal. I found myself thinking, "Why would anyone volunteer to be stretched on the rack for a stressful, mostly thankless, unpaid job?" I offer my impression simply as data to consider. I could be projecting or misinterpreting what happens.  - Mark D Worthen PsyD   (talk)  05:38, 4 July 2018 (UTC)
 * That reminds me: Another reason to not be an admin is that some hackers target admin accounts.  This is partly done to put spam on the main page, but it's also partly because if you want to install malware, then what better way to do it than to hack into the account of someone who can instantly install Javascript, with no pesky, interfering code review processes, on one of the most widely visited and trusted websites in the world?  Even five minutes could infect thousands upon thousands of machines.  Oh, and once you're in, there's apparently a way to steal other people's accounts, so one weak password on just one admin's account can cause problems for everyone.  So for those of you who are already admins, please, please, please use a unique and l-o-n-g password for your accounts (I believe that MediaWiki will accept passwords significantly longer than 200 characters), and then go read m:Help:Two-factor authentication and consider setting it up.  Also, the devs (including volunteer devs) have been talking about splitting this risk off from regular admins for about a decade, and I'm hoping they'll finally get that done this year.  So things may be getting better soon.  But in the meantime, protect your accounts.  WhatamIdoing (talk) 19:03, 5 July 2018 (UTC)
 * There's really only one thing that's important in making a strong password: length. A truly random string of just 12 lower case letters will take a couple of hundred years to crack by brute force using today's technologies. All the rest of the stuff that so-called "security experts" shove down our throats is just theatre that they conjure up to justify their existence. If you think I'm being too optimistic, use 16 letters instead. That would probably keep you safe for about 90 million years. The electric costs for the hacker would exceed the sum of the world's worth, which ought to discourage most of them. --RexxS (talk) 20:42, 6 July 2018 (UTC)
 * , From your description above it appears that randomness is also a factor. How much is the strength compromised by being reasonably easy to memorise? &middot; &middot; &middot; Peter (Southwood) (talk): 07:09, 7 July 2018 (UTC)
 * , does Mediawiki accept passwords with spaces, or does it assume that the first space indicates the end of the password? &middot; &middot; &middot; Peter (Southwood) (talk): 07:09, 7 July 2018 (UTC)
 * A lack of true randomness is only weaker if the hackers know the way in which the randomness is deficient. Against a simple brute-force attack, it's not very important. For Wikipedia I use a pass-phrase – that is, a series of words, including spaces and some uncommon words. It is naturally easier to remember, but has to have many more characters than a random sequence. A phrase with 10 words would take about the same time to crack via a 4000-word dictionary attack as 25 random letters would take using brute force (about 500 million million million years and the hackers won't have any electricity by then). Of course it feels like it takes almost that long to type it in. --RexxS (talk) 11:52, 7 July 2018 (UTC)
 * I don't think that randomness is important, but "anti-non-randomness" probably is. Common passwords (e.g., qwerty, password, google, 123456) should be strictly avoided.   can probably tell us how spaces are processed in MediaWiki.  (I know that MediaWiki won't complain if you use a password that contains spaces, but I don't know if they're ignored in the calculations.)
 * What you need to know: Special:ChangeCredentials is your friend (and will instantly ask for your current password).  Some web browsers (including Firefox, but not Safari) will show the date when you saved your password there; that can give you an idea of how long yours has been around.
 * Also, please don't look at RexxS's numbers and think it means a 12-character password is unassailable. It's probably "good enough" – and it is dramatically better than the average 5-character-long password – but you'll want to keep in mind that those 200-year estimates are usually based on a single consumer-grade computer, which is a rather quaint approach in a world with 20 billion internet-connected computers, many of which can be "borrowed" by any determined hacker.  A modest cracking array will be able to crack a 12-character, all-lower-case password in a year or less, and a mid-sized botnet will be much faster.  A dozen characters is "good enough" because almost none of us are going to have someone who's going to dedicate thousands of dollars' worth of effort to discovering our passwords, but cracking a 12-character, all-lowercase password is technologically feasible.  Most of us only need to defend against the more casual attackers – the guy who's manually testing all the accounts to see who's used popular bit of profanity as their password, or someone who's got a list of passwords from a different cracked website and is seeing whether anyone has the same username and password here.
 * If this subject interests you, then you might also be interested in https://www.grc.com/haystack.htm  This interactive tool shows how long it would take to check every possible password of a particular type (e.g., all possible combinations of 12 lowercase characters:  centuries for a single computer, but mere minutes for a massive cracking array).  Statistically speaking, you can safely assume that your password is going to be towards the middle of this range (i.e., neither the first one attempted nor the last).  Finally, the good news here is that the Technology folks will notice if a major hacking attempt is underway, and they can take steps to discourage it.  But you really can help by setting up a decently long password (everyone) and adding two-factor authentication (if you're an admin).  WhatamIdoing (talk) 18:22, 7 July 2018 (UTC)
 * Thanks for putting my figures into context. Yes, a massive parallel setup will crack the 12 letter passwords in much less time than I indicated, but folks who spend that much money on super-powerful rigs won't be using their investment on trying to get access to your Wiki account, so 12 is probably "good enough". I have my generator set to 20 characters (because I can), if that helps the context. The other thing I really should have said is that the most insecure thing you can do is re-use a password over multiple sites. It's reassuring that the Tech department will keep an eye out for attacks, but that is no defence if you use the same name and password here as you use on the website for your local grocery shop. If the grocery shop has its password file stolen, it can be cracked at the hacker's leisure, and then they will only need one attempt to log into your account here (unless you have 2FA). HTH --RexxS (talk) 21:32, 7 July 2018 (UTC)
 * MediaWiki doesn't have any restrictions on what you use as your password, beyond certain policy restrictions like a minimum length. It takes whatever you submit as-is and runs it through a PBKDF2 key-derivation function to get the password hash stored in the database. Anomie⚔ 19:43, 8 July 2018 (UTC)
 * MediaWiki doesn't have any restrictions on what you use as your password, beyond certain policy restrictions like a minimum length. It takes whatever you submit as-is and runs it through a PBKDF2 key-derivation function to get the password hash stored in the database. Anomie⚔ 19:43, 8 July 2018 (UTC)

Comment on draft
Your comments on Draft:TRIORAL rehydration salts are welcomed. Please use either Yet Another Articles for Creation Helper Script by enabling, or use  directly in the draft. Thank you. Sam Sailor 09:37, 9 July 2018 (UTC)
 * Commented. And user needs to disclose... Doc James  (talk · contribs · email) 13:41, 9 July 2018 (UTC)

Requested move
Input is requested at Talk:Vocal_cords. Natureium (talk) 14:22, 9 July 2018 (UTC)
 * — Please post at WP:ANAT as well. Carl Fredrik  talk 16:57, 9 July 2018 (UTC)

Commons Picture of the Year
c:Commons:Picture of the Year/2017/R2/Gallery is in the second round of voting now; if you're looking for a little break, then head over and take a look. While you're there, you might want to look at c:Category:Featured pictures on Wikimedia Commons and relevant categories to see whether there are any images that might be useful in your favorite articles. WhatamIdoing (talk) 21:29, 10 July 2018 (UTC)


 * have voted, please vote--Ozzie10aaaa (talk) 10:41, 11 July 2018 (UTC)
 * ditto. Bondegezou (talk) 11:02, 11 July 2018 (UTC)

Research funding by JDRF
We have a conflicted edit request from an intern at one non-profit (a watchdog of other nonprofits) about another non-profit's level of research funding, sourced to the watchdog's website. See Talk:JDRF.

Not strictly medical, but related to stuff we do here. Am interested in others' thoughts. Am unsure what is good, in this situation. Jytdog (talk) 17:43, 12 July 2018 (UTC)
 * commented--Ozzie10aaaa (talk) 20:27, 12 July 2018 (UTC)

Wiki Project Med Foundation is Applying to be a Thematic Organization
Please support here Wiki_Project_Med/Application Doc James  (talk · contribs · email) 17:15, 12 July 2018 (UTC)
 * great endeavor--Ozzie10aaaa (talk) 14:58, 13 July 2018 (UTC)

Feedback request
I'm requesting feedback on article content in nootropic. The issue is described at Talk:Nootropic.  Seppi  333  (Insert 2¢) 07:52, 13 July 2018 (UTC)
 * thank you for posting(Pharmacology is a very important field)--Ozzie10aaaa (talk) 10:24, 16 July 2018 (UTC)

Gene infoboxes and readability
I am sure everyone here has been to one or two articles about genes and felt that some improvements could be made to the readability of infoboxes. See BRCA1 or MLH1 for an example of an infobox, then try to imagine this from the perspective of a lay reader or someone with an affected relative. I have proposed some ways these could be made easier to read and help convey some general information and feel some input from additional editors (currently there are just two of us) would be useful. Please contribute at Wikipedia_talk:WikiProject_Molecular_and_Cell_Biology.--Tom (LT) (talk) 11:25, 15 July 2018 (UTC)
 * Wikipedia_talk:WikiProject_Molecular_and_Cell_Biology is a very bad idea. Jytdog (talk) 16:42, 16 July 2018 (UTC)

Level of reading dispute
Hi, I am having a dispute with User:Sbelknap about reading levels in articles about drugs. See the version of Clonidine here, compared with this one. There is some discussion at my talk page here.

There has been a discussion about reading level at WT:MEDMOS (the only thing there now). Am also placing a note of this at WT:PHARM since this was pharmacology content.

What are folks' thoughts? Jytdog (talk) 13:25, 9 July 2018 (UTC)
 * Yes simplification is important. Doc James  (talk · contribs · email) 14:10, 9 July 2018 (UTC)
 * "Everything Should Be Made as Simple as Possible, But Not Simpler" - Albert Einstein
 * I think their version of the lead would be great in a section on mechanism. The lead is for random people who just want to know a simple summary of the drug and google it. The rest of the article can dive into more depth. Natureium (talk) 14:16, 9 July 2018 (UTC)
 * Many ledes for pharmacology articles are wrong, trivial or both. I strongly agree with Doc James that simplicity is important. However, the root of simplicity for drugs should be in the conceptual articles, not the drug articles. The drug articles should use technical terms that are defined in simple terms in the conceptual articles. For example, This is the first sentence I proposed for the lede for the clonidine article: Clonidine (trade names Catapres, Kapvay, Nexiclon, Clophelin, and others) is a centrally-acting sympatholytic α2 adrenergic agonist My intent was to provide hyperlinks to articles that would explain "centrally-acting" "sympatholytic", "alpha-2 adrenergic receptor", and "agonist." Alternatively, this could be expressed using multiple sentences. Either way, these concepts are the essence of what clonidine is in a pharmacology context. Thus, these should be in the lede. Here is the lede for adrenergic drug from Encyclopedia Britannica: "Adrenergic drug, any of various drugs that mimic or interfere with the functioning of the sympathetic nervous system by affecting the release or action of norepinephrine and epinephrine. These hormones, which are also known as noradrenaline and adrenaline, are secreted by the adrenal gland, hence their association with the term adrenergic. The primary actions of norepinephrine and epinephrine are to mediate the “fight-or-flight response.” Thus, they constrict blood vessels (vasoconstriction), which increases blood pressure, and accelerate the rate and force of contractions of the heart. Adrenergic drugs that produce or inhibit these effects are known as sympathomimetic agents and sympatholytic agents, respectively." — Preceding unsigned comment added by Sbelknap (talk • contribs)
 * I disagree strongly with the assertion that "the root of simplicity for drugs should be in the conceptual articles, not the drug articles". I think it is the other way round. An average reader coming across an article about a drug is less likely to understand pharmacological and physiological concepts than those finding their way to articles on drug classes. A patient is not necessarily aware that his drug is of a certain type, and that simvastatin is a statin isn't even immediately obvious, if you do not know that statins exist. That said, we have ample room for detailed description in the body of articles, and Jytdog's lede summary is better for this reason.
 * Also, arguing that Encyclopedia Brittanica does things one way is not an especially strong argument around here. Carl Fredrik  talk 23:15, 9 July 2018 (UTC)
 * Like Doc James, I am of the mind that articles about drugs should be as simple as possible (without eroding the validity of the content). Generally, we should strive to simplify or define jargon (or provide both) when applicable (e.g. using the term "dry mouth" in place of "xerostomia"). The purpose of these efforts is to improve the accessibility of medical content for a lay audience. I believe that this should be true even for more "complex" sections, such as the "Mechanism of Action" subsection under "Pharmacology."
 * In reference to the clonidine article specifically, I think it would be a good idea to break up the MoA § by indication/effect. I may put some work into that to display my meaning. I concur with Carl Fredrik that drug articles should be the focus of simplification, since I imagine that these receive greater lay-person traffic than technical, "conceptual" topics in pharmacology. ― Bio chemistry 🙴 ❤   03:07, 10 July 2018 (UTC)
 * This "centrally-acting sympatholytic α2 adrenergic agonist" should never occur within the first sentence of any article. You only learn this stuff near the end of medical school or into residency.
 * One should not need a professional degree in the subject matter in question to find a Wikipedia article useful. Doc James  (talk · contribs · email) 10:18, 10 July 2018 (UTC)
 * I am more familiar with science education in the US and to a lesser extent, in the UK and the EU, and so can't speak to the situation in Canada. In the US concepts of "adrenergic" "cholinergic" and "dopaminergic" are introduced to elementary school students age 11 - 13, are covered again in Freshman Biology in High school (age 14), are covered in more detail in AP Biology during the Junior or Senior year (age 16 - 18), in college during Introductory Biology (age 18 - 19), and for biology majors during Neurobiology (age 19 - 21), then in medical school physiology, again in medical school pharmacology, and during clinical rotations in pediatrics, medicine, Emergency medicine. The concept agonist and antagonist are introduced in Freshman High School Biology. The concept of alpha 1 and alpha 2 adrenergic receptors, beta 1 and beta 2 adrenergic receptors, dopamine receptors, and acetylcholine receptors are first introduced in AP Biology in High School. The concept of centrally-acting vs. peripherally-acting are covered in AP Biology. I served as a Science Olympiad coach for elementary school students aged 11 - 13 for several years. I do have some idea what an intelligent laymen knows and what they can learn. Our team finished second in the nation. I have also taught pharmacology and clinical pharmacology to medical students for 34 years. For 10 years, I was on the National Board of Medical Examiners Pharmacology Committee that created the exams for the USMLE Step 1 Exams. Perhaps Doc James misremembers his own educational experience. Regardless, his comments about education on neuroscience do not accurately desccribe the experience of American students.Sbelknap (talk) 19:00, 10 July 2018 (UTC)
 * That's surprising. It hasn't been that many years since I was in school, but I didn't learn about the concepts of "adrenergic", "cholinergic", and "dopaminergic" until I was an undergrad. I probably learned about antagonists/agonists in high school, but I took a lot more science classes in high school than were required. I think the rest of the concepts you talk about I learned during undergrad. Natureium (talk) 19:04, 10 July 2018 (UTC)
 * Perhaps not so surprising. There is a tendency to have amnesia for initial experience with material that is also covered later. Both you and Doc James appear to be victims of this phenomenon. It might be best to move to some more objective source of evidence than our own idiosyncratic experience. Here is the Khan Academy lesson for High School AP Biology on neurotransmitters: https://www.khanacademy.org/science/biology/ap-biology/ap-human-biology/modal/a/neurotransmitters-their-receptors

I am beginning to understand the reasons why the wikipedia pharmacology articles are so terribly bad. The community of editors interested in these pages is completely wrong-headed as to what an intelligent laymen knows (or knew in high school). You all simply do not know your audience.Sbelknap (talk) 19:43, 10 July 2018 (UTC)
 * Or... you could be wrong. Jytdog (talk) 21:47, 10 July 2018 (UTC)


 * "In the US concepts of "adrenergic" "cholinergic" and "dopaminergic" are introduced to elementary school students age 11 - 13". I got no dog in this fight, but I can tell you that this isn't part of the Canadian curriculum at any point. I'm a 33 year old man with a Master's degree in physics who took all sciences possible in K-12, and 2 biology classes for my undergrad, and I couldn't tell you what those things are without looking them up. This is the first I hear of them. Headbomb {t · c · p · b} 22:18, 10 July 2018 (UTC)
 * Which is another matter entirely. Your assertion that you don't remember these things does not mean that you never learned these things. Sbelknap
 * I can't remember what I never learned in the first place. Those are specialist terms. I know what dopamine and adrenaline is, but this not K-12 material, and the word "adrenergic" does not evoke adrenaline to the non-expert. And absolutely no one would have any clue what acetylcholine. I recognize 'acetyl' because I have some background in chemistry, but hell if I know what choline is, or that "cholinergic" would refer to it. Headbomb {t · c · p · b} 01:49, 11 July 2018 (UTC)


 * Well, I tried to find evidence to back up your claim, and I've failed. Here are two searchable links to 7th-grade biology textbooks, and I have been unable to find anything in them that suggests that these concepts are even named at this level.  Not even simpler concepts, like "serotonin" and "dopamine", are turning up for me.  The focus seems to be on anatomy ("optic nerve" and "dura") rather than function.  Perhaps someone else wants to have a go at seeing whether they can find these concepts in a seventh-grade biology textbook?  I don't doubt that a dedicated child with special extra coaching could understand this; I'm just unable to find any evidence that it's presented to in the regular biology curriculum at this age.  Only 5% of American kids are going to be taking AP Biology.  Unless we're writing Wikipedia articles for the educationally privileged 5%, then "let's put it in the first sentence, because they cover this in AP biology" doesn't seem like an appropriate plan.  WhatamIdoing (talk) 01:15, 11 July 2018 (UTC)
 * For whatever it's worth, I got through a major in biochemistry and taught various biology courses to first- and second-year science and medicine students in Australia for several years before I ever learned "adrenergic" or "cholinergic". Neither term appears in the >1300 pages of our general biology textbook for first-years.  Adrian J. Hunter(talk•contribs) 03:06, 12 July 2018 (UTC)
 * Lets take the lede for clonidine as an example:
 * "Clonidine is a medication that is used to treat high blood pressure, attention deficit hyperactivity disorder, anxiety disorders, tic disorders, withdrawal (from either alcohol, opioids, or smoking), migraine, menopausal flushing, diarrhea, and certain pain conditions."
 * A definition ought to first say what a thing is, then (maybe) say what it is used for; e.g., Hammer n. A hand tool consisting of a handle with a head of metal or other heavy rigid material that is attached at a right angle, used for striking or pounding.
 * The key facts about clonidine are that it is 1. sympatholytic 2. alpha 2 adrenergic agonist 3 centrally-acting
 * It is marketed under many brand names.
 * False. It is hardly "marketed" at all. Instead, it is sold as a generic drug. Even the patch has a generic version.
 * The adverse effects include sedation, dry mouth, and low blood pressure.[1]
 * The Adverse drug effects paragraph in the lead ought to have a sentence for "most frequent" and a clause for "most serious." The essential information is that most adverse effects are mild and tend to diminish with continued therapy. The most frequent (which appear to be dose-related) are dry mouth, occurring in about 40 of 100 patients; drowsiness, about 33 in 100; dizziness, about 16 in 100; constipation and sedation, each about 10 in 100. The most serious adverse effects are low blood pressure, depression, and slow heart rate.
 * Clonidine treats high blood pressure by stimulating α2 receptors in the brain stem, which decreases peripheral vascular resistance, lowering blood pressure.
 * No. The blood pressure lowering effects of clonidine are caused, at least in part, by activating alpha 2 receptors in the lower brainstem.
 * Clonidine also may cause bradycardia, probably due to a temporary increase in vascular resistance caused by clonidine stimulating α2 receptors in smooth muscles in blood vessels.
 * No. Clonidine increases parasympathetic outflow, which may slow the heart rate.
 * This blood pressure raising effect is seen when the drug is given intravenously, and is not usual when clonidine is given by mouth or by the transdermal route.[5]:201-203
 * To what antecedent is "This" referring?
 * This sort of awfulness occurs throughout the pharmacology article ledes. When one looks through the revision history, one finds attempts to correct the errors, but these are shouted down by wikilawyers. Pharmacology is a science. If an editor does not respect that, then that editor is more of a vandal than an editor. Sbelknap (talk) 22:58, 10 July 2018 (UTC)
 * I don't think I agree with this analysis. From my POV, the "key fact" sounds a lot more like "your grandfather is probably taking the stuff in that bottle to treat high blood pressure" than "biochemists classify it in these ways".
 * On a tangent, a few years back, we collected comments from readers about Wikipedia articles. The comments on rare-disease articles have stuck with me.  They didn't ask for more information about how to classify it or what the etiology was, or anything like that.  They asked whether their friend's baby was going to die.  I learned from this that the stuff that interests our intellectual, ivory-tower contributor base is very different from what our readers are actually looking for.  IMO, if your target is the rare person who is going to look up all of those classification terms, then you can count on that person to read past the first sentence.  You can, in fact, count on them reading the entire article, which is something that almost nobody actually does.  But the one who just needs to learn "Scary Disease doesn't kill kids" or "Those are Grandpa's high blood pressure pills"?  They don't need that.  WhatamIdoing (talk) 01:39, 11 July 2018 (UTC)
 * The wikipedia editors for rare diseases don't seem to agree with your perspective. Here is the beginning of the lede for Maple syrup urine disease (MSUD), also called branched-chain ketoaciduria, is an autosomal recessive[1] metabolic disorder affecting branched-chain amino acids. It is one type of organic acidemia.[2] The condition gets its name from the distinctive sweet odor of affected infants' urine, particularly prior to diagnosis, and during times of acute illness.[3] — Preceding unsigned comment added by Sbelknap (talk • contribs) 03:17, 11 July 2018 (UTC)
 * That kind of introductory sentence is exactly why we got those complaints about the articles' contents. :-/   WhatamIdoing (talk) 23:30, 11 July 2018 (UTC)

Here is a good example from the first paragraph of a technical wikipedia article: "Esterel is a synchronous programming language for the development of complex reactive systems. The imperative programming style of Esterel allows the simple expression of parallelism and preemption. As a consequence, it is well suited for control-dominated model designs."
 * Notice that the terms "synchronous programming language", "complex reactive systems", "imperative programming style", "parallelism", "preemption", and "control-dominated model designs" are used in this first paragraph of the lede. If one doesn't understand these terms, then most of them have hyperlinks to decent articles that explain them. That is the model that the pharmacology articles ought to use.

Each technical discipline has its own core vocabulary. There are about 400 core technical words in pharmacology. About 100 or so of these words cover 90% of the need for technical vocabulary. This attempt to eschew technical words in a technical article is sheer folly. It is not what technical articles for other disciplines do. Here is another example: "Staggered tuning is a technique used in the design of multi-stage tuned amplifiers whereby each stage is tuned to a slightly different frequency. In comparison to synchronous tuning (where each stage is tuned identically) it produces a wider bandwidth at the expense of reduced gain. It also produces a sharper transition from the passband to the stopband. Both staggered tuning and synchronous tuning circuits are easier to tune and manufacture than many other filter types."

The function of stagger-tuned circuits can be expressed as a rational function and hence they can be designed to any of the major filter responses such as Butterworth and Chebyshev. The poles of the circuit are easy to manipulate to achieve the desired response because of the amplifier buffering between stages.

Applications include television IF amplifiers (mostly 20th century receivers) and wireless LAN. Sbelknap (talk) 23:52, 10 July 2018 (UTC)
 * Basically, say it twice in the lead - first simply, then with the technical terms. What about the unintelligent layman, which using your standards would seem to include most of us? Johnbod (talk) 01:24, 11 July 2018 (UTC)
 * On the Esterel example: I happen to have the advantage of knowing what those "vocabulary words" are, but that text didn't really tell me anything about that programming language.  So if you know as little about Esterel as I did, here's the answer:  it's an old programming language that would be useful for programming things like stoplights, banks of elevators, vending machines, and (in the realm of biology) tools to measure reflexes.  It looks like the main commercial use might be audio processing equipment.  That class of programming languages is better at handling simultaneous input (e.g., two vehicles arriving at an intersection at exactly the same time) than normal async programming languages.  If I were working on that article, I'd probably start with a sentence such as "Esterel is an uncommon programming language that is often used to control machines and computers that react to real-time events.  It may be used to process audio or to control hardware, such as elevators and traffic lights".  I'd bet that the typical person will get a lot more out of my description than out of the list of classifications.  WhatamIdoing (talk) 01:55, 11 July 2018 (UTC)
 * A technical article in wikipedia ought to use the core technical vocabulary of the relevant discipline. Otherwise, the article is shorn from its intellectual base. Instead of redefining the core technical words across hundreds of articles, use hyperlinks. That is their purpose. There is actual research on hyperlinks: they help the average reader more than the highly-motivated reader.
 * I read the Esterel lede differently. The first paragraph of the lede for the Esterel article accurately and precisely specifies what the language is. The lede is accessible to the non-expert, providing the hyperlinks so as to understand the descriptors in the lede.
 * Esterel 5.0 is not an "old" language. It is in active use in industry and in academia. In fact, I use Esterel in my research. The Esterel family of languages includes Lustre, which was used to build SCADE, the system that runs the Airbus 380. I expect that your characterization of Esterel as a stoplight language would make Gerard Berry laugh. Sbelknap (talk) 02:59, 11 July 2018 (UTC)
 * Berry's first publication about Esterel was in 1983. That's the same year that the Apple Lisa (selling for "just" the equivalent of $), MS-DOS version 2, Microsoft Word version 1, and Lotus 1-2-3 v1 were released.  3.5" floppies were brand-new, and available in single-sided only, and most consumers were still swapping 5.25" ones.  Almost nobody had hard drives at home, and when they did, they often held barely 5 or 10 MB.  Consumers were coveting Intel's 286 chip, and larger businesses were looking at fancy "minicomputers" that were "only" as big as a washing machine, rather than the size of a truck, not counting the tape drive or expensive, washing-machine-sized hard drives you needed for your data.  The fastest computer in the world was the Cray, and despite being big enough to double as furniture, it had less computing power and less memory than the iPhones being sold today.  In 1983, "the internet" had 1,000 hosts, "the backbone" was critical infrastructure (DNS was brand-new), and it would have zero websites for another two decades.  Borland's C++ and MS Windows were still dreams, and PostScript was still in John Warnock's garage.  So, yeah:  by most people's standards, 1983 really is "old" for computing, even if some of us are old enough to personally remember it.
 * Oh, and if Berry's amused that Esterel can be used for traffic control, then he's been amused at least since he published that idea himself in 1999 (e.g., page 10, section 1.2). WhatamIdoing (talk) 23:28, 11 July 2018 (UTC)

If this approach you all are using to writing pharmacology articles is so great, then why are the articles so terrible? Have you all considered that using folksy language instead of technical terms renders these articles uneditable? Isn't this the real reason why a 14 year old article with hundreds of edits is still filled with errors? For example, here is one edit:


 * (Changed Sympathoolytic to the correct Sympathomimetic in line 1. Clonidine is an alpha 2 agonist, therefore a sympathomimetic. (medical student)) (undo)

Let us imagine that this well-meaning medical student saw this first sentence in the lede instead of the pile of rubble that was present at the time: clonidine is a centrally-acting, sympatholytic alpha-2 adrenergic agonist. This student would then stop and think and realize that his own understanding was close to being correct, but not quite. He would not have then introduced yet another error into the article. You all are thinking about some lowest common denominator reader that will read the article. But editors are also readers, and they will unintentionally vandalize complex descriptions written in folksy language. They are more likely to respect technical language, reviewing it for accuracy, and perhaps improving it. I suggest that the wikipedia pharmacology articles are uneditable in their current form. A new approach is needed. Lets use the approach that other technical articles use. Sbelknap (talk) 03:43, 11 July 2018 (UTC)


 * See WP:OTHERCRAP and WP:NOTFINISHED. Headbomb {t · c · p · b} 03:33, 11 July 2018 (UTC)
 * On the contrary, Sbelknap, I believe that the use of jargon is what easily contributes to mistakes—both in interpretation of sources, and in a reader's understanding. Wikipedia is meant for the lay public, so let us write it in such a way that it is accessible to them. However, let us do so in a way that is stimulating and useful to those with more advanced knowledge. I am not convinced that it is somehow impossible to write both clearly and informatively. I do not pretend myself to be an expert in such writing, but it is something I strive for. What say you re: the ADHD sub§ under the MoA§? ― Bio chemistry 🙴 ❤   03:56, 11 July 2018 (UTC)
 * There is some poor-quality evidence that clonidine may have a modest effect in ADHD in adolescents. I notice that the sub for this article does not cite Hirota's meta-analysis, which perhaps it should. AFAIK, there is no evidence that clonidine acts via the central alpha-2 adrenergic mechanism in ADHD (and no cite is provided in the sub you point to), nor is there evidence that alpha-2 adrenergic receptors are of some central importance in ADHD. There were some studies in an animal model of ADHD, but my understanding is that this model is not considered relevant to the human ADHD phenomenon. Perhaps if there were studies cited on this, we could see. Sbelknap (talk) 11:04, 11 July 2018 (UTC)
 * Steve, above you wrote that you work with kids in science olympiads who are in grade school and AP biology classes. When you write "intelligent layperson" you appear to be talking about people way, way over on the flat part of the bell curve. Super-smart people who are actually studying this stuff. That is horribly skewed and absolutely not who we write for.
 * No one here will argue that our articles do not need improvement. They do.
 * But as long as you keep generating content aimed at people who are a) super smart and b) educated in biology/pharmacology (these are not the same sets of people, necessarily) you are going to keep wasting your own time and the time  of experienced editors.  That is not building the encyclopedia but rather squandering the most valuable resource we all have -- time. Jytdog (talk) 20:05, 11 July 2018 (UTC)
 * I think you missed the point of my writing entirely, and are trying to argue for the incorporation of primary research here. The cited article is a review that describes the connection between alpha-2A ARs in ADHD. My point was to get your feedback on whether you thought the section, in terms of its readability (which is the topic we are discussing at present, yes?) was acceptably comprehensive while also accessible to a lay person. My intention was to demonstrate to you that it is indeed possible to accomplish both; we don't need to overwhelm our readers with jargon. Could I have summed the section up with a one-liner like, "Clonidine's alpha-2A AR agnoism induces a sympatholytic effect on downstream prefrontal cortex neurons."? Probably, but that would be practically useless to a layperson.― Bio chemistry 🙴 ❤   03:01, 12 July 2018 (UTC)


 * Jytdog, (and other interested editors) I challenge you to provide one example of a wikipedia article on a medical drug that meets the wikipedia criteria for a wikipedia featured article. Those criteria are here: [] One article.
 * The content I have attempted to create is for intelligent laypersons, which is a large fraction of any human population, anywhere. I am suggesting that as long as editors of wikipedia pharmacology articles are prohibited from using the core technical vocabulary of the discipline, the quality of those articles will remain poor. In my opinion, the *cause* of the poor quality is, in part, the policies and culture that are unique to medical editing on wikipedia. Many of these pharmacology articles have existed for more than a decade, yet remain rife with error. If you review the revision history for the pharmacology articles you will notice that many attempts at correction of errors are thwarted. The pharmacology articles lag behind other technical articles in wikipedia, which have steadily improved. I am suggesting that the prohibition on the use of the core technical vocabulary of pharmacology in these articles is the *cause* of the poor quality of the pharmacology articles relative to those for other STEM disciplines. Editors in other areas of wikipedia apparently accept/encourage the use of core technical vocabularies.
 * Doc James stated, "One should not need a professional degree in the subject matter in question to find a Wikipedia article useful." I provided evidence that contradicted this idea that a professional degree was required to understand the core vocabulary of pharmacology. Here is that video Khan Academy lesson for High School AP Biology on neurotransmitters: https://www.khanacademy.org/science/biology/ap-biology/ap-human-biology/modal/a/neurotransmitters-their-receptors
 * Perhaps this is progress, as you now concede that some high school students achieve mastery of some of the technical vocabulary of pharmacology. Many less accomplished high school students also are familiar with the meaning of "adrenergic", "cholinergic", "dopaminergic", "serotonergic", "agonist", "antagonist", etc. I note that my use of the word "agonist" has been removed from wikipedia articles that contain the word "antagonist" a few sentences away.
 * The wikipedia guidelines and culture do not respect pharmacology as a science. There are good reasons for using technical words, as they facilitate clear communication. Technical words are widely used in wikipedia, with hyperlinks to articles that explain them, often very well. Pharmacology is an outlier in wikipedia on this issue.
 * Jytdog, you are certainly wise to not waste the time of experienced editors. However, under the current wikipedia culture, the efforts of editors of pharmacology articles *is* being wasted. The product of these efforts is quite poor. The pharmacology articles are condescending to their audience. I frankly don't see utility of most of these articles for any audience. The quality problems could quickly be addressed by using the same approach to technical vocabulary that is used in other STEM articles.
 * I propose that we compile a core vocabulary of pharmacology terms (agonist, half-life, alpha adrenergic, etc), with broad input from interested wikipedia editors. I envision eventually using about 100 terms. We would first change wikipedia pharm policies to permit use of these core technical terms in wikipedia drug articles. We would then want to expend some effort to improve the pharmacology vocabulary articles. Many articles for these core terms exist, though some improvements would be advisable if we are going to use them to build the articles for specific drugs. Is there a mechanism on wikipedia for doing modified Delphi trials to build such a list? Or is there some other suitable mechanism we could use? Perhaps just a wikipedia page for core terms of pharmacology? What do you suggest? Sbelknap (talk) 21:44, 11 July 2018 (UTC)
 * You complain fiercely about the poor quality of articles but you make edits like this, where you persist in writing crappy citations that other people need to work over to make them usable in an online encyclopedia, even as you put tons of weight on clickable wikilinks. Doc James and I have both showed you the tool that allows you to create an elegant citation with links in seconds. You blow that off.
 * You also quote something without saying who or what you are quoting (I learned not to do that in junior high school).
 * You do not understand our mission and are so busy being contrarian that you are screwing up very basic editing details and wasting everyone's time.
 * This place survives in the tension between individual boldness and minding the community (what you dismiss as "wikilawyering" is actually the "constitution" that holds this place together). You are all the way over on the "bold" side. It is not a sustainable approach to editing. Jytdog (talk) 23:30, 11 July 2018 (UTC)
 * Strongly against any proposal that would create a mandated list of vocabulary terms to use whilst writing WP:PHARM articles. I'll be frank Sbelknap: even if such a list existed, I would not use it. It would be an overwhelming task to create, let alone memorize, such a list, and any attempt to apply it would present an insurmountable, bureaucratic burden—especially for new editors.― Bio chemistry 🙴 ❤   02:49, 12 July 2018 (UTC)
 * I accept Jytdog's criticism that I did not use the correct tool to edit in this case. I apologize for this, but did not know (still do not understand) that I was doing anything incorrectly. I will stand by the *content* of what I wrote, which was a big improvement over what was there. The net effect is that this article is worse than it could have been. Perhaps rather than fierce attacks on process errors, gentle reminders and requests to repair an editing error could be used? Or is that not part of the etiquette of the wikipedia community?
 * I note that Jytdog does not address my above proposal, which was exactly the attempt to engage the community that Jytdog seems to be asking for. Perhaps Jytdog could share his opinion on my proposal? I openly solicited Jytdog's opinion in my comments directly above. Jytdog invited me to this page to engage in this discussion and I agreed to participate. I concede that process matters. Will Jytdog concede that content matters? Perhaps Jytdog can provide us with a *single* pharmacology article that meets the criteria for a wikipedia featured article? Sbelknap (talk) 00:02, 12 July 2018 (UTC)
 * You are asking the wrong person about FAs; I find that whole structure to have gone wrong and to have become an engine of drama-mongering, and I stay far, far away from it.
 * I already said that much of WP, including our health content, needs work.
 * That is why this new crusade of yours is such a tragedy. Please just try to learn the basics. Formatting citations is explained in WP:MEDHOW. Please actually read WP:MEDMOS and try to follow it.  Learn what we actually do here and how we do it and why before you try to reform everything. I try to explain these very basic things in User:Jytdog/How. I want our articles to be high quality and accessible to every day people.  That takes work.  Letting your academic scientist flag fly when you write here is not OK.  You need to condescend (one of my favorite theological terms -- to come down to be with) and write for our target audience without giving up rigor. This is hard.
 * I have said that you could be immensely valuable here. Instead you keep wasting our time and yours with these crusades. Please just learn what we do and how and why and try to follow it, and work. Once you show that you "get it" -- that you are what we call clueful -- you will be able to persuade people here.  Jytdog (talk) 01:42, 12 July 2018 (UTC)
 * The tragedy is that thousands of editors have contributed to wikipedia drug articles and nearly all of them are flawed. I have spent many months learning what you all do and why. I have pored through revision histories for dozens of drug articles. There appears to be a serious problem, I intend to fix this problem. If the current approach works, then please point me towards one medical drug article that meets the criteria for a wikipedia featured article. One article. I will use it as a learning device for my edits. Sbelknap (talk) 03:33, 12 July 2018 (UTC)
 * I spend a lot of time looking at pages and how they got to their present state as well. This place is truly insane. Anybody can come here and write anything.... and you know, bell curves being what they are, most edits are bad or mediocre, some are good and a few are very good. But even the very good ones fall out of date unless somebody new who is competent comes along and updates what that person did. It just lifts my heart when I see somebody make a good edit and I whoop when I see a great one.
 * There are a lot of ways that people make bad edits. Some of them are vandalism or spam, some are just wrong, some remove good, well sourced content, some are "news" that are not "accepted knowledge"... some put UNDUE weight on some aspect, some are hyper-technical. There are many ways to go wrong.  There is content i would love to build but I spend most of my time fixing bad content.  Just doing maintenance.
 * And it kills me when I see somebody who could be making great, mission-oriented edits making bad ones. You really could do great things here Steve. But when I see edits like this, I will fix them. They are not good edits here .  Here.  You could do so much better.
 * Again, I do not care about FA. You are asking the wrong person. If you want to ask me to point you to an article with pharmacology content that I think is really good and on-mission, I will try to find some. Jytdog (talk) 04:03, 12 July 2018 (UTC)
 * Sbelknap, if you want to see an FA – a process that was basically "tuned" to fit history and the other humanities, and which IMO does not fit technical subjects perfectly – then see Bupropion or any of the other articles listed at WikiProject Pharmacology. You should be able to find the exact revision that was approved by looking in the boxes at the top of the talk page.  WhatamIdoing (talk) 17:34, 12 July 2018 (UTC)
 * The current version of the bupropion article is quite similar to the FA version. The lede (current version) begins:
 * Bupropion, sold under the brand names Wellbutrin and Zyban among others, is a medication primarily used as an antidepressant and smoking cessation aid.[7][8][9] It is an effective antidepressant on its own, but is also used as an add-on medication in cases of incomplete response to first-line SSRI antidepressants.[10]
 * There are only a few published reports describing clinical trials of bupropion. Based on what little evidence is available, bupropion is a weak antidepressant, having almost no effect on depression. There is a high-quality meta-analysis published in 2018 in a good journal that synthesizes the available evidence on bupropion as an antidepressant.
 * On the single most important issue, antidepressant efficacy, the wikipedia bupropion article gets it spectacularly wrong. There are many other errors in the bupropion article. I counted 10 serious errors after reading carefully through the entire article once (~45 minutes of reading). I would rate the quality of the wikipedia bupropion article as very poor. I would agree that the wikipedia bupropion article is better than nearly all the other wikipedia drug articles I've read. I expect that many readers of the wikipedia bupropion article will want to know whether or not bupropion is effective, and the article misinforms them on this point.
 * So what are we to do? Sbelknap (talk) 21:37, 12 July 2018 (UTC)
 * Well, that claim is supported by a source from 2005, so I'd start by wondering whether recent review articles held a different view. A quick search of reviews in core clinical journals didn't turn up anything recent, but perhaps a more thorough search will turn up a couple of useful sources.  WhatamIdoing (talk) 06:42, 13 July 2018 (UTC)

For what it's worth, I don't think the bupropion article has been compliant with the WP:FA criteria since I first read through it 3–4 years ago. As for the clonidine article, it's fine to be as detailed/technical as one wishes when describing a drug's pharmacodynamics in the body of the article, but article leads are supposed to be pretty dumbed down. Normally, I'd dedicate 1 of 4 lead paragraphs to a drug's pharmacology for a fairly lengthy drug article, using really basic/simplistic language – while still maintaining accuracy – to describe its pharmacodynamics.

In any event, bupropion probably needs to undergo a WP:featured article review.  Seppi  333  (Insert 2¢) 09:49, 13 July 2018 (UTC)


 * Lets be very clear here. There has never been evidence that bupropion was particularly effective for depression. The serious flaws in this article were present at the time it was first recognized as an FA. The article has been of very poor quality since it was a stub. It has gained length but never improved. I've gone through the revision history, which is fascinating. I note that Jytdog, Doc James, and others who are high-frequency editors have made many contributions to the bupropion article. Somehow they all missed the fact that there is very little evidence available about bupropion and what is available shows that thre the drug is ineffective. Numerous other errors remain uncorrected.


 * Something is very wrong here. If one were to deliberately create drug articles that obscure the truth, one could hardly have done worse. There are many high quality articles in other technical areas of wikipedia but none of them are about drugs. Those who are knowledgeable about drugs are greeted with hectoring wikilawyers who attack them until they stop editing. Look at the revision histories and then look at the editing history of knowledgeable drug article editors who are attacked. Please explain how I am wrong here. I am struggling mightily to assume good intentions by those who police the wikipedia drug articles. The evidence speaks for itself.


 * I again ask knowledgeable wikipedia editors to kindly provide links to wikipedia drug articles that they consider to be of high quality. I have not found any. If I am to achieve the "clueful" state that Jytdog mentions, I will need at least one example of how this community and these processes (which are unique to this subculture of wikipedia) have produced at least one wikipedia drug article that is high quality. Please advise. Sbelknap (talk) 11:54, 13 July 2018 (UTC)
 * Even if every single fact is completely backwards, those articles are still good models for writing style. The FAC regulars are better at "brilliant prose" (a requirement for FA status) than at evaluating scientific evidence (which isn't even mentioned in the FA criteria).  WhatamIdoing (talk) 15:55, 13 July 2018 (UTC)
 * There are only a few entries at category:FA-Class pharmacology articles, and most of those could use a review. That said, Linezolid does seem to have a lede that we could afford to emulate elsewhere. Serpin's lede is rather more technical than necessary, but is still encouraging. LeadSongDog come howl!  16:21, 13 July 2018 (UTC)


 * The linezolid article is of poor quality. Lets through selected statements in the lede.
 * "Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics."
 * This definition fails to distinguish linezolid from the other drugs used to treat MRSA, such as trimethoprim/sulfamethoxazole, vancomycin, daptomycin, tigecycline, or quinupristin/dalfopristin. The purpose of a definition is to *define*. The defining characteristics are that linezolid has and oral formulation and that it binds to the 50S subunit of the bacterial ribosome, blocking formation of the initiation complex for protein synthesis. Here is a better intro:
 * Linezolid is an oxazolidinone antibiotic that blocks initiation of protein synthesis by binding to the 50S subunit of the bacterial ribosome. Linezolid has antibacterial activity against many strains of methicillin-resistant staphylococcus aureus and other firmicutes (gram-positive bacteria). Linezolid is effective when given by mouth, which is an important advantage compared to vancomycin, daptomycin, tigecycline, or quinupristin/dalfopristin, all of which are available only in parenteral formulations.


 * Serious side effects may include serotonin syndrome…
 * No. This ought not be in the lede, as this is rarely, if ever, a clinically relevant issue. A nuanced discussion is here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805572/


 * "Linezolid was discovered in the mid 1990s and was approved for commercial use in 2000."
 * No. This does not do justice to the facts. A group of scientists at duPont spent a good chunk of their lives working on this, and wikipedia consigns them to oblivion. This reminds me of how Pfizer "discovered" penicillin. (Pfizer "discovered" penicillin by noticing that Fleming and Florey had already discovered penicillin. Pfizer did discover how to make a lot of money manufacturing penicillin, though.) The oxazolidinones are synthetic drugs that were first discovered in the 1980s by scientists at duPont. Scientists at Pfizer later did further research exploring the structure:activity relationship of oxazolidines, and identified linezolid as a drug with good antibacterial activity and good oral bioavailability.

These drug article ledes contrast with other articles in wikipedia which have both a lay audience and a technical audience. Consider the wikipedia entry for moose:


 * "The moose (North America) or elk (Eurasia), Alces alces, is the largest extant species in the deer family. Moose are distinguished by the broad, flat (or palmate) antlers of the males; other members of the family have antlers with a dendritic ("twig-like") configuration. Moose typically inhabit boreal forests and temperate broadleaf and mixed forests of the Northern Hemisphere in temperate to subarctic climates."

Notice all the technical words used in the moose article. Here is a version of the moose lede written in the style of a wikipedia drug article:
 * "The moose is a type of deer with a big thing on its head that lives in the woods and drinks water."

-- — Preceding unsigned comment added by Sbelknap (talk • contribs) 20:41, 13 July 2018 (UTC)
 * This
 * "Linezolid is an oxazolidinone antibiotic that blocks initiation of protein synthesis by binding to the 50S subunit of the bacterial ribosome. Linezolid has antibacterial activity against many strains of methicillin-resistant staphylococcus aureus and other firmicutes (gram-positive bacteria). Linezolid is effective when given by mouth, which is an important advantage compared to vancomycin, daptomycin, tigecycline, or quinupristin/dalfopristin, all of which are available only in parenteral formulations."
 * is unacceptably too technical. You are writing for the wrong audience. You are getting no traction here at WT:MED for your advocacy to write at the level of a biomedical journal article. You could try taking this to the wider community but you will get even less as most people will find that incomprehensible. Jytdog (talk) 00:33, 14 July 2018 (UTC)
 * Jytdog, if you could provide examples of wikipedia drug articles that you consider to be of high quality, I would be grateful. Thanks. Sbelknap (talk) 02:15, 14 July 2018 (UTC)
 * By this time it is a pointless exercise, as you will simply say "it is not written at the level of a biomedical journal" and write something boring and clueless like we would find in any standard pharmacology book. We all know already what that kind of writing looks like; we read it every day and many of us write that way outside of WP. This is by now just tiresome. It is hard to write in this genre. You don't want to do that work, so be it. Your edits will not stick. Jytdog (talk) 02:38, 14 July 2018 (UTC)
 * I have given very specific examples of major flaws in articles that are claimed to be good. These errors had nothing to do with the use of technical vocabulary. Jytdog continues to mischaracterize my points. My critiques are available above for anybody to read. There are many technical articles in wikipedia that are of high quality. Jytdog promised to tell us one drug article that is high quality. I would be grateful to Jytdog if he would do so. Sbelknap (talk) 19:49, 14 July 2018 (UTC)

I think what you wrote is fine for the body of the article, but leads are supposed to use very simplistic language. As an example of how you might revise what you wrote to be more suitable for a lead, compare the following two paragraphs:"(1) Linezolid is an oxazolidinone antibiotic that blocks initiation of protein synthesis by binding to the 50S subunit of the bacterial ribosome. Linezolid has antibacterial activity against many strains of methicillin-resistant staphylococcus aureus and other firmicutes (gram-positive bacteria). Linezolid is effective when given by mouth, which is an important advantage compared to vancomycin, daptomycin, tigecycline, or quinupristin/dalfopristin, all of which are available only in parenteral formulations.""(2) Linezolid is an oxazolidinone antibiotic that inhibits bacterial protein production. Linezolid has antibacterial activity against many strains of methicillin-resistant staphylococcus aureus and other gram-positive bacteria. Linezolid is effective when given by mouth, which is an important advantage compared to vancomycin, daptomycin, tigecycline, and quinupristin/dalfopristin, all of which are poorly absorbed following ingestion. (NB: I'm assuming these drugs all have poor oral bioavailability)" This type of simplistic summary of its pharmacology isn't really any different than the pharmacology content in the lead of Beta-Hydroxy beta-methylbutyric acid being a stupidly simplistic summary of Beta-Hydroxy beta-methylbutyric acid.  Seppi  333  (Insert 2¢) 02:49, 14 July 2018 (UTC)
 * I like your edits. This is an improvement over what I wrote. However, if one were to put this in the linezolid lede, I expect that it would be reverted almost immediately by Jytdog, Doc James, or one of the other well-meaning drug article police. Sbelknap (talk) 19:55, 14 July 2018 (UTC)

After going through the pharmacology section, the linezolid article didn't seem that bad. It was a little out of date, but not terribly so. Most of the information was accurate w.r.t. a 2018 pharmacology review. The main issue with linezolid is that its references are inconsistently formatted and it has a lot of older refs due to it being largely written back in 2009 and the article lacking a maintainer. I expect some of the article content is still dated, so it likely needs further attention in other sections of the article. As for the lead, I made a few minor changes but it seemed fine (i.e., compliant with MOS:LEAD) overall.  Seppi  333  (Insert 2¢) 07:42, 14 July 2018 (UTC)
 * I pointed out what I consider to be serious flaws in the lede of the linezolid article, which I described above. I read carefully through the main article, and found many errors. Its not just out-of-date, some of this content was wrong when it was first introduced. Sbelknap (talk) 19:49, 14 July 2018 (UTC)

, you are quite right that there does not exist a single drug/med article that meets FA (declining) standards. FA is a broken process; it is, though, the best Wikipedia has to offer in an overall broken model. Many of your criticisms of drug articles are spot on, but your approach is not likely to yield the productive results you wish. The problem with our drug articles is not reading level (alone), not the broken FA process, and not the need for lists of acceptable words. It is, quite simply, that there are almost no competent editors on Wikipedia who work on drug articles. was one of the best, and he is hardly active any more. The problem with our drug articles is that Wikipedia was, for a long time, populated by pharm editors who a) could not write, but b) had chips on their shoulders. As you have many valid criticisms, perhaps you will alter your approach and find a group of editors willing to collaborate on article improvement. (Good luck with that-- I have found it harder and harder as Wikipedia loses once good editors. ) Sandy Georgia  (Talk)  14:59, 14 July 2018 (UTC)
 * I agree with you that there is a shortage of pharmacology editors on wikipedia. The question is, why? If one works through the revision history for the drug articles, one finds competent, knowledgeable editors who make useful edits. Often, these competent pharmacology editors are attacked by wikilawyers who are long on process knowledge and short on content knowledge. If one then looks through the contributions logs for these competent pharmacology editors, one finds that after attacks by wikilawyers, their contributions precipitously decline or cease. Interested editors can go and look for themselves. This looks like a death spiral to me. Sbelknap (talk) 19:49, 14 July 2018 (UTC)
 * Some claim that those with expertise in pharmacology are wiki-defective in some way. Perhaps there is something to that. However, I believe the major problem lies elsewhere. Pharmacology is a science. It seems to me that the current culture does not understand or respect that pharmacology as a science. I've read many, many non-pharmacology articles and made a few edits in technical areas other than pharmacology, and the culture there seems much more in keeping with what I understand the mission of wikipedia to be. The drug article community seems to resent experts and chases them away.
 * I'm looking for a drug article that is of good quality. Perhaps such an article would be helpful as a template for the community. I haven't found one so far. Do you know of any, User:SandyGeorgia? Sbelknap (talk) 19:49, 14 July 2018 (UTC)
 * User:SandyGeorgia I have thought of you a few times throughout this discussion. The goal of this thread was get wider input on reading level. SBelknap has been continually raising other issues, which has made it hard to focus on this. I realize you have your own set of things you are unhappy about and that some of these other issues align with them, but part of the work we need to do to bring Sbelknap into the community is help him learn what we do in Wikipedia, and how and why.  In your view, is the level of reading of the content that he has generated and that he has proposed here, appropriate for Wikipedia or not? Jytdog (talk) 14:12, 15 July 2018 (UTC)


 * I don't understand why so many claim that FA is a broken process. I find it works quite well, with solid comments the vast, vast majority of the time. It's certainly fine for science topics, we brought Quark to FA-level, it took three times to get, specifically because it was hard to make the CKM matrix section in (Quark) accessible to layfolk, but once you do through it, you really do end up with something polished. Headbomb {t · c · p · b} 15:27, 14 July 2018 (UTC)
 * I agree that there are many technical articles in wikipedia that are of high quality. There are no high-quality drug articles that I've seen. If you know of one, please tell us. The question is, why are the wikipedia drug articles so much worse than other technical articles? Sbelknap (talk) 19:49, 14 July 2018 (UTC)
 * , Quark was promoted almost a decade ago, after I archived it twice. The FA process today has little to do with what it was a decade ago.  Since then, intense scrutiny on articles has become very rare, articles are allowed to languish at FAC for months on end, many FAs are passing on minimal support, many more get no review at all, a small core of regulars review and support only each others' work (which is rarely to standard), and you can find basic grammatical issues in just about any FA passed.   , there are few good technical FAs these days-- the problem is not only pharm.  The problem with pharm articles is similar to the problem with math articles; the editors who focus in those areas refuse to understand that the technical issues are not the problem with the articles-- the attitude and lack of writing skill and collaboration is.  We see the same thing happening today in medicine articles; non-med editors who come in to polish writing are treated rudely and leave.  As I told you, the problem in pharm articles is almost entirely related to the chips on shoulders.  If a core group of editors with drug knowledge would realize that the problem is in the writing, and work with good writers to bring their technical expertise to the article, a good drug article would be possible.  It would also help if med editors would make room for the real writers to work alongside them.  Sandy Georgia  (Talk)  13:01, 15 July 2018 (UTC)

After going through parts of both linezolid and bupropion, it occurred to me that most of our older pharmacology/medical FAs likely need updates in certain sections. A lot of the sources in linezolid/bupropion are outdated (i.e., >10 years since publication), even in the medical uses sections; that's particularly problematic for statements about absolute or comparative efficacy which are cited to these sources. In relation to disease-related FAs, this is also problematic for treatment sections that still cite outdated sources. If we don't make an effort to maintain our FAs, they eventually won't be FAs anymore.  Seppi  333  (Insert 2¢) 08:14, 15 July 2018 (UTC)

Disruption
— There seems to be overwhelming consensus that what you are doing or suggest doing should not be done. To continue to pursue or argue for it is WP:DISRUPTIVE. Carl Fredrik talk 07:24, 15 July 2018 (UTC)
 * I strongly disagree. He's made some good points about article content that needs improvement, provided useful references, and he's made some constructive edits; the only real issue here is that his approach to editing is a little counterproductive due to the lack of familiarity that all new Wikipedians have with our policies/guidelines.  If our goal is to retain new editors (particularly ones that are knowledgeable of a technical subject area), then we should be pointing him to the appropriate policy/guideline sections (e.g., MOS:LEAD, WP:NPOV, etc.) that explain how we go about writing encyclopedia articles and why we approach it that way in order to help him make purely constructive edits.  It would be even better to fix/build upon his partially constructive edits rather than revert them since that actually illustrates what the issue is and how to address it. I apologize if "he" is in fact a "she", but I'm making an assumption based upon our rather excessive gender bias.
 * To be frank, the way you are handling this is – IMO – very unhelpful for pursuing that goal (i.e., editor retention).  Seppi  333  (Insert 2¢) 07:51, 15 July 2018 (UTC)
 * I'm not suggesting a net negative, but that pushing for an overhaul in how we write ledes, and doing so in the face of strong consensus is disruptive. I'm convinced Sbelknap can do good work, but trying to change the ledes of every article to correspond to his idea of what should be included — is not beneficial. There is a fine line between WP:DONTBITE and WP:PACT. Carl Fredrik  talk 08:10, 15 July 2018 (UTC)
 * Doc James did something interesting: he added a new row for "drug class" to the lede table summarizing drug data. I wonder if we had a "pharmacodynamics" section in the lede table if that would help wikipedia attract and retain editors. Presently, many of the drug articles don't read like science articles. This tends to repel editors or potential editors who have expertise in pharmacology. We already have a "pharmacokinetics" section. What do you all think? Sbelknap (talk) 12:35, 15 July 2018 (UTC)
 * Wikipedia is not intended to read like a scientific article, and articles on drugs are certainly no exception. The pharmacodynamics section can be fleshed out with in-depth information, but the lede is intended to be written "as simply as possible". This sets limits on how much information can be conveyed, and I don't think it would be an improvement to include more information than is done in most of the articles on WP:RTTS. Carl Fredrik  talk 13:33, 15 July 2018 (UTC)
 * Oh, you mean the Template:Infobox drug. Yes, that is certainly possible. In fact it already occurs, as in Fluticasone_propionate/salmeterol. Ping  Carl Fredrik  talk 13:37, 15 July 2018 (UTC)
 * Yes! The fluticasone/salmeterol infobox looks good. Thanks. Sbelknap (talk) 13:44, 15 July 2018 (UTC)
 * — Do you see how it is being done, with the - and  -parameters? Adding these would be very useful. It is possible that we could rename the current fields to   (however that doesn't allow the same nesting).  Carl Fredrik  talk 06:20, 16 July 2018 (UTC)
 * Enhancing the infobox in this way would be terrific. Sbelknap (talk) 21:36, 16 July 2018 (UTC)
 * CFCF, that is baloney. Sbelknap could probably work on attitude, but s/he is not the only one with a problem here.  Sandy Georgia  (Talk)  13:05, 15 July 2018 (UTC)
 * I agree. I've been trying not to get involved in these disputes because I think it's largely unproductive, but this applies to both sides of these arguments. Skbelnap has made good points but is going about implementing them in the wrong way and needs to be more flexible, but the people arguing against him are refusing to consider the potential positives from his contributions. Yes, the lead should be simple for all the people who receive a prescription and google it just to get a little more information, but there is also room in the article for in-depth information on drug mechanism that would interest people that bother to read the entire article. My perspective is that most of our pharm articles are good, but could be improved. Saying they're garbage because you disagree with them even though they are sourced is not helpful. Natureium (talk) 14:17, 16 July 2018 (UTC)
 * No one has suggested that. Carl Fredrik  talk 13:24, 15 July 2018 (UTC)
 * User:SandyGeorgia, please see this ANI thread. I have been hopeful that SBelknap could contribute productively in other areas (and I remain hopeful - he could be so productive here!) but the same behavior and approach to WP that led to that TBAN are being displayed here, in this very thread (he is the expert and what he says and wants to do is correct; he is opposed by incompetent wikilawyers, etc).  In most of this thread he has deflected the discussion away from the concrete and discussable issue of reading level. If we could remain focused on that, it could help him learn about that, which would be a good thing. Jytdog (talk) 14:40, 15 July 2018 (UTC)
 * Jytdog continues to misrepresent my POV. I respectfully request that Jytdog stop misrepresenting my POV.


 * Here is my perspective on readability of drug articles:
 * 1. The potential audience for drug articles spans a broad range of expertise about pharmacology.
 * 2. The vast majority of potential readers will have virtually no knowledge about pharmacology.
 * 3. The vast majority of potential readers seek a simple answer: what problem does this drug solve? what harm can this drug cause? is this drug better than some other drug?
 * 4. A few potential readers seek easily understood explanations beyond a simple answer: how does the drug work? who discovered/invented the drug?
 * 5. A small fraction of potential readers seek accurate technical explanations of the pharmacology or clinical pharmacology of the drug.
 * 6. An infinitesimally small fraction of potential readers have some degree of mastery of pharmacology.
 * 7. The pool of potential editors for improving drug articles may draw from groups 3, 4, 5, 6. (*NOT* just experts. Even rank amateurs can learn and contribute!)


 * Here is my perspective on technical content of drug articles:
 * 1. There are currently no drug articles that are free of serious factual errors. (I invite any of you to provide a counter-example.)
 * 2. There have been many, many failed attempts by wikipedia editors to fix serious factual errors in drug articles. (Go look through revision histories and see for yourself.)
 * 3. These attempts to fix serious factual errors are often blocked by wikipedia process experts who hector editors attempting to fix factual errors, driving them away.
 * 4. Anonymous editing of wikipedia is essential to the wikipedia enterprise.
 * 4. There is no adequate mechanism in wikipedia to assess and mitigate COI by anonymous wikipedia editors.
 * 5. The potential for serious COI for drug articles is enormous. Conflicts might be financial, ideological, or personal.
 * 6. The pool of drug article editors appears to be shrinking. (perhaps due in part to general trends affecting wikipedia, perhaps in part due to the wikipedia drug article subculture.)
 * 7. The currency of drug articles appears to be worsening. (As science advances, information of *central relevance and importance* is often not being incorporated into drug articles.)
 * Two questions for you all: Is this a reasonable perspective on readability and content of drug articles? If so, what is to be done to improve these articles?
 * Sbelknap (talk) 00:57, 16 July 2018 (UTC)
 * Yes, that is a very reasonable perspective — what I think was missed early on was your point:
 * 2. "The vast majority of potential readers will have virtually no knowledge of pharmacology".
 * There has been a lot of work put into keeping the introductions to articles accessible to lay people — and since neither pharmacology or pharmacy invovles any greater degree of communication to the public, it is understandable that it is difficult.
 * It does not do to provide three simple sentences followed by a difficult one that is only for those who have sufficient prior knowledge — because readers shut off as soon as they see something they don't understand. If sentence 4 is difficult it decreases the amount of readers that persist to sentence 5,6,7.
 * To be frank, this is not the first time we've run into the same discussion. We should do our best to accomodate both those with very little, and very much knowledge of pharmacology — and keeping the lede simple and attaching in-depth pharmacodynamic information in the sidebar (infobox) is probably the ideal solution. At best we can compare article ledes with the information leaflets that come with drugs, which contain in-depth information under a separate pharmacodynamics section (at least they do in Sweden).
 * As for COI, that is a very relevant discussion, however it is probably more fruitful to have it independently of this one. Carl Fredrik  talk 06:20, 16 July 2018 (UTC)


 * And so you continue hijacking the discussion about reading level into yet another crusade, and continuing with the pharma shill gambit, which you were already admonished for at ANI, even. Really.
 * And the answer to your Big Deflecting Crusade is the same as it always is. We know already that content is bad in places and is always in need of updating, improvement, and maintenance (fixing bad content that gets added). This is not Big News.
 * As long as WP remains WP (a volunteer project open to anybody), the answer to how to do those things, is work by the volunteers who are here, grounded on the policies and guidelines. Which includes writing at appropriate levels, and not writing crappy citations that other people have to clean up.
 * More broadly there have been all kinds of efforts to attract and groom new editors. They are what they are. If where you are going is that you want to have signed, curated pages, Nupedia is thataway, and quite dead. Jytdog (talk) 09:38, 16 July 2018 (UTC)
 * As to ideology as a source of COI, that is unlikely in the case of those supporting science-based content over woo, but entirely plausible in someone who is, for example, actively involved in publishing reports of adverse drug events. Guy (Help!) 10:29, 16 July 2018 (UTC)

Re: There are currently no drug articles that are free of serious factual errors. (I invite any of you to provide a counter-example.) – until recently, there were 3 pharmacology FAs that were promoted in recent years AND kept up-to-date by an active Wikipedia editor: psilocybin, amphetamine, and β-hydroxy β-methylbutyric acid (HMB). The first was written largely by, but he recently left Wikipedia. The latter two were written largely by (wrote: the "Chemistry" sections) and I (wrote: everything else). The first (psilocybin: an illicit substance) and last (HMB: a biomolecule/medical food ingredient/supplement) of those three are not pharmaceuticals although they do satisfy the loose/pharmacological definition of a drug; the second (amphetamine) obviously is a pharmaceutical.

β-hydroxy β-methylbutyric acid is comprehensive relative to currently published literature and I doubt you'll be able to find a factual error in it, but amphetamine currently does not include explicit coverage of its efficacy for narcolepsy and exogenous obesity (the latter of which became an FDA-approved indication of racemic amphetamine under the brand name "Evekeo" after it was promoted to FA status) as well as the molecular neuropharmacology/mechanism of action which underlies its therapeutic effects for those conditions. Right now, I only have suitable references for writing the section on narcolepsy. For obesity, I'm waiting for a review article to cover peripheral TAAR1 signaling in relation to the mechanism of action of amphetamine (and derivatives like phentermine) for treating obesity. That said, if you think there are any significant omissions in either of these FAs (besides what I mentioned above for amphetamine) or you have suggestions for improvements, I'd be interested in hearing your feedback on the associated talk pages (i.e., Talk:Amphetamine and Talk:Beta-Hydroxy beta-methylbutyric acid). The leads of both articles reflect how featured article reviewers expect the leads of drug articles to be written.  Seppi  333  (Insert 2¢) 05:19, 17 July 2018 (UTC)

FWIW, maintaining a drug FA and attempting to keep it comprehensive for 3+ years after its FA promotion date is not an easy task.  Seppi  333  (Insert 2¢) 05:29, 17 July 2018 (UTC)


 * I like the amphetamine article. The current version could serve as a basis for a high-quality article. The writing style is clear. There are some opportunities for making the amphetamine article more accurate and more interesting. As a start, and to give an idea of what could be done, I've edited one sentence in the first paragraph of the lede and moved it to the second paragraph. I've also added three sentences to the second paragraph. (I didn't put in all the hyperlinks. I added one reliable citation. Some of the info I've added is from my own notes, so we would need another citation or two, which I can track down.) This level of detail for history seems about right to me for the lede. Sbelknap (talk) 01:46, 18 July 2018 (UTC)

HgenetInfoDB
The gene database HgenetInfoDB does not have its own article (and apparently never has) but it is still linked from over a dozen articles. However the database itself appears to be offline, suggesting that all wikilinks to it and links to urls in the database should be removed (typically they are included in infoboxes like the one on 5-HTTLPR). IntoThinAir (formerly Everymorning) talk  16:33, 12 July 2018 (UTC)
 * All the infobox ones can be removed by altering the Template:Infobox single nucleotide polymorphism. Would be good to mention their. Doc James  (talk · contribs · email) 17:17, 12 July 2018 (UTC)
 * It looks like it was added in 2008 by a logged-out editor from Denmark. I don't know who to ask/who might know about this.  Maybe a question for WikiProject Molecular and Cell Biology?  WhatamIdoing (talk) 20:59, 12 July 2018 (UTC)
 * This seems to be resolved, as I have removed it myself from the infobox Doc James refers to above. IntoThinAir (formerly Everymorning) talk  03:39, 18 July 2018 (UTC)

Category:Rare genetic syndromes
Almost all the articles in Category:Rare syndromes are genetic. Do we really need a separate category? Natureium (talk) 19:06, 18 July 2018 (UTC)
 * nope! but it would be best to consolidate in the less specific one for the inevitable strays. Jytdog (talk) 20:04, 18 July 2018 (UTC)

intechopen.com
This publishers is listed as possibly predatory. Wondering peoples thoughts? Doc James (talk · contribs · email) 15:19, 14 July 2018 (UTC)
 * seems so --Ozzie10aaaa (talk) 17:47, 14 July 2018 (UTC)
 * I think that article is talking about something else – a fee to send the original draft to the publisher, with no idea of whether it will be accepted, rather than a fee to have the article made free-as-in-beer after it has cleared peer review and been accepted by the editor. Even quite respectable publications such as PNAS charge authors hundreds or thousands of dollars to make the paywall go away.  The BMJ charges an article publication fee of £3000 (US $4800).  WhatamIdoing (talk) 22:24, 16 July 2018 (UTC)


 * 443 uses on Wikipedia. Guess we start removing them: insource:"intechopen.com" Carl Fredrik  talk 07:29, 15 July 2018 (UTC)
 * Interestingly, 5 InTech journals appear to have been published by Sage Publications for about 2 years now. More criticism of InTech can be read here. This seems to paint a mixed picture when it comes to whether their journals are predatory: the publisher has been criticized as predatory, but why would Sage pay to acquire 5 of their journals if it didn't think they were legit? IntoThinAir (formerly Everymorning)  talk  01:10, 17 July 2018 (UTC)
 * In the case of Sage set the fee to a one-time $1200 per article after peer review and acceptance. Was that the same when InTech published it? LeadSongDog  come howl!  22:44, 18 July 2018 (UTC)

color x-ray
should be placed in an article or made standalone article ...IMO--Ozzie10aaaa (talk) 20:43, 12 July 2018 (UTC)
 * It's a press release -- not even a primary source. Without better sourcing, there is no justification for doing anything with it. Looie496 (talk) 00:17, 13 July 2018 (UTC)
 * We already have an article on medipix, the underlying CERN technology. If/when RS become available for the "color" x-ray device, they could be added to the medical imaging subsection there. -- 00:29, 13 July 2018 (UTC)
 * Picture looks like a CT image not a plain X ray. Agree will need better sources. Can go here Medipix Doc James  (talk · contribs · email) 13:42, 13 July 2018 (UTC)
 * University of Canterbury--Ozzie10aaaa (talk) 13:56, 13 July 2018 (UTC)
 * As far as I can make out, what they are doing is CT scanning using a mixture of X-ray energies, and using differential attenuation of different frequencies to assign colors to voxels. Looie496 (talk) 16:23, 13 July 2018 (UTC)
 * Normally the use of human-visible colors to represent an invisible-energy spectrum is referred to as "false color". Accordingly, this should be called a "false-color x-ray" or "false-color CT image". The more that the image looks realistic, the more important it becomes to name it correctly to avoid misleading the viewer. LeadSongDog come howl!  22:53, 18 July 2018 (UTC)

Comorbidities
Are not mentioned in MEDMOS for diseases. Where do you all think they should go? Am looking at this edit to Diabetes... Jytdog (talk) 02:42, 6 July 2018 (UTC)


 * Hmm. The ideal approach might depend upon the details.  Here's some ideas off the top of my head:  ==Epidemiology== if they co-exist but don't really interact.  ==Pathophysiology== if the causes are related.  ==Symptoms== if the obvious presence of one means you should investigate the existence of the other.  ==Treatment== if it affects treatment (e.g., "Many people with Disease also have Scary, in which case they can't take this Scary-exacerbating drug").
 * Other people may have other/better ideas. WhatamIdoing (talk) 16:30, 6 July 2018 (UTC)

One alternative is to introduce the following division into MEDMOS: Just thinking about it now makes sense to me, and it's odd that it hasn't been raised before. It would of course require splitting out Differential diagnosis from the  sections, but this isn't a formal issue and will be resolved over time. Another alternative is to place it as follows: Though this feels less natural for me. Carl Fredrik talk 16:40, 6 July 2018 (UTC)
 * Use of the actual word may be a bridge too far for a general audience. Most people will cope with the word "diagnosis", or even "differential" thanks to medical shows... I doubt "comorbidity" will slide down quite so easily. Basie (talk) 07:29, 7 July 2018 (UTC)
 * It would require some short clarification of what a comorbidity is on each article; to which an alternative is  (To further make myself clear I am in favor of splitting comborbities from other sections, because a treatment section would be overly detailed with such information, and it is more likely to be read if it is under an independent header. We know that most people only read the sections they believe are relevant to them.)  Carl Fredrik  talk 10:23, 7 July 2018 (UTC)
 * If we want people to read it, then we should use a plain-language title.
 * I think that the separate vs same section question depends upon how many there are. In other conditions, there might only be one sentence to write.
 * Are you thinking about a strict definition of comorbidities (technically unrelated diseases that happen to occur at the same time (e.g., common cold + broken arm = comorbidity) or a broader one (diabetes causes kidney failure)? If the latter is more important, then a   section (or something like that; for all the things that are commonly present together because they have related causes/processes) might be more appropriate.   WhatamIdoing (talk) 17:25, 7 July 2018 (UTC)
 * When is it appropriate to include very technical information, well beyond the comprehension of 95% of visitors, e.g., drugs (medications) and the chemical information in the sidebar? Only in sidebars? What about the fact that many medical & other health professionals use Wikipedia to learn about all sorts of topics related to their studies/profession? Are they not an important part of our audience? (I understand that Wikipedia is not a medical textbook.) I don't mean to come across as harshly challenging or the like. These are simply questions I've had for a while that this discussion brought to mind.  - Mark D Worthen PsyD   (talk)  23:17, 7 July 2018 (UTC)
 * , I took the liberty of moving your comment out of the middle of WAID's. I agree, it's a tricky needle to thread but I don't think the fact that health professionals use Wikipedia means we should allow the content to drift further away from something a general audience will understand. Cheers, Basie (talk) 23:26, 7 July 2018 (UTC)\
 * yes, the general audiance is our main target for articles...IMO--Ozzie10aaaa (talk) 10:44, 19 July 2018 (UTC)


 * Comment I typically put them under "signs and symptoms" Doc James  (talk · contribs · email) 10:59, 8 July 2018 (UTC)


 * I should have noted in the OP that I looked for past discussions of this; they are brief and not resolved.
 * 2006 Wikipedia_talk:WikiProject_Medicine/Medical_genetics_task_force/Archive_1
 * 2007 Wikipedia_talk:Manual_of_Style/Medicine-related_articles/Archive_2
 * 2012 Wikipedia_talk:WikiProject_Medicine/Archive_27 -- Jytdog (talk) 15:50, 9 July 2018 (UTC)